Category: EQS Newswire

EQS via SeaPRwire.com / 2026-06-18 / 17:14 UTC+8 （香港，2026 年 6月 18 日）– 亚博科技控股有限公司（香港联交所股份代号：8279，以下简称“亚博科技”或“公司”）今日宣布，公司已根据主板上市规则第9B章，正式向联交所提交转板上市申请[1]。 董事会认为，随着公司业务规模持续扩大及战略拓展不断深化，申请转往主板上市，将为公司下一阶段的发展提供更适宜的上市平台。依托公司在数字支付、银行业务、财富管理、跨境结算及区域金融协作等领域的多元化业务布局，转往主板上市将有望提升公司作为综合金融科技集团的品牌认知度。这不仅有助于深化与用户、商户、金融机构、商业合作伙伴及投资者的互动与联结，也将助力公司把握更多业务发展机遇。 同时，主板市场拥有更广泛的投资者基础及更高的市场认可度，有助于提升投资者对公司的认知与信心，扩大公司在机构投资者及国际资本市场中的覆盖范围，进一步优化股东基础及投资者结构，提升股份交易流动性，并为公司长远发展提供更大的灵活性。申请转往主板上市符合公司的发展战略与股东的整体利益。 作为阿里巴巴集团成员公司，亚博科技致力于成为全球领先的综合性金融科技集团，立足综合金融业务、商业赋能及本地消费者服务业务，并积极布局包括黄金及贵金属交易创新技术服务等在内的新兴业务领域，逐步构建覆盖多元场景的“全链条、全方位金融服务”能力。2022年，公司收购澳门通股份有限公司及其附属公司，将业务版图拓展至支付领域；2024年，又完成对蚂蚁银行（澳门）的控股权收购，进一步夯实“支付+金融”的平台基础。目前，公司正积极拓展创新金融业务，并于2026年初与香港黄金交易所达成合作，将为其设计、开发及维护一个安全且稳定的电子交易、清算及结算平台，助力香港国际黄金交易中心建设，并将推动黄金及贵金属市场数字化升级。 截至2026年3月31日止年度，亚博科技总营收约7.6亿港元，同比增长约23.7%，经营规模持续扩大。其中，实体与数字银行业务表现尤为亮眼，期内收入约2.25亿港元，同比大幅增长约232.7%。高增速业务占比持续提升，收入结构进一步优化，这标志着过去几年来公司整体的战略转型已见成效。未来，公司将继续深化金融科技生态建设，并把握粤港澳大湾区及国际市场发展机遇，稳步推进全球化业务布局。 -完- 关于亚博科技控股有限公司 亚博科技是阿里巴巴集团成员公司，于百慕大注册成立，其股份在GEM上市（股份代号：8279），并获纳入MSCI全球微型股指数。作为一家综合性金融科技集团，亚博科技的核心业务大致分为四大类： (1) 综合金融业务： (i) 数字支付业务： (a) 澳门通卡 (b) MPay (c) 商户收单服务1 (ii) 实体与数字银行业务： (a) 个人和中小企数字银行服务2 (b) 财富管理服务3 (2) 商业赋能及本地消费者服务业务： 生活服务、文娱服务、为商户提供营销技术服务及电商平台 (3) 黄金及贵金属交易创新技术服务 (4) 彩票业务4 1 该业务亦包含原于“支付相关硬件供应”项下呈列的业务范畴。 2 该业务包含存款、贷款、转账及跨境汇款、跨境电商/供应链融资等业务。 3 该业务包含原于“互联网证券投资、账户服务、保险代理服务及客户自助网点银行服务”项下呈列的业务范畴。 4 该业务包含彩票硬件销售、透过实体渠道代销彩票及其他整合服务。 详情请浏览 www.agtech.com [1] 股东及潜在投资者务请注意，转板上市须待（其中包括）联交所批准相关申请后方可进行。概不保证转板上市将获得联交所批准及许可。因此，转板上市可能会或可能不会进行。股东及潜在投资者于买卖股份时务请审慎行事。 2026-06-18 此新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

EQS via SeaPRwire.com / 18/06/2026 / 17:14 UTC+8 (Hong Kong, June 18, 2026) – AGTech Holdings Limited (Stock Code: 8279 on the Stock Exchange of Hong Kong Limited, hereinafter referred to as “AGTech” or the “Company”) announced today that it has formally submitted an application to the Stock Exchange in relation to the proposed transfer of listing of the Company's Shares from GEM to the Main Board pursuant to Chapter 9B of the Main Board Listing Rules[1]. The Board believes that, as the Company continues to expand its business scale and deepen its strategic diversification, the Proposed Transfer of Listing would provide a more appropriate listing platform for the Company’s next phase of growth. In particular, taking into account the Company’s diverse business operations in areas such as digital payments, banking, wealth management, cross-border settlement and regional financial collaboration, the Board believes that a listing on the Main Board would enhance brand recognition of the Company as a comprehensive financial technology group, strengthen its engagement with users, merchants, financial institutions, business partners and investors, and support the Company’s ability to pursue commercial opportunities in its current market positioning. Meanwhile, the Main Board offers a broader investor base and higher market recognition, which will help enhance investor awareness of and confidence in the Company, expand the Company’s coverage among institutional investors and in international capital markets, further optimize its shareholder base and investor structure, improve the liquidity of its shares, and provide greater flexibility for the Company’s long-term development. On the basis of the foregoing, the Proposed Transfer of Listing is beneficial to the future growth and development of the Company and is in the overall interests of the Company and the Shareholders. As a member of Alibaba Group, AGTech Holdings is committed to becoming a leading global comprehensive financial technology group. It focuses on diversified services including full-scale financial services, commerce enablement and local consumer services, while actively expanding into emerging business areas such as innovative technology services for the gold and precious metals trading, thereby developing the capability to provide “end-to-end, all-round financial services” across diverse scenarios. In 2022, the company completed the acquisition of Macau Pass Holding Ltd. and its subsidiaries, significantly expanding its footprint into the payment sector. In 2024, it completed the attainment of the controlling stake in Ant Bank (Macau) Limited, further solidifying its “payment + finance” platform foundation. Currently, AGTech is actively broadening its innovative financial business. In early 2026, the company reached a collaboration with the Hong Kong Gold Exchange (HKGX) to design, develop and maintain a secure and stable electronic trading, clearing, and settlement platform. This initiative aims to support Hong Kong's development as an international gold trading center and drive the digital transformation of the gold and precious metals market. For the year ended March 31, 2026, AGTech recorded a total revenue of approximately HK$760 million, representing a year-on-year growth of about 23.7%, reflecting a continuous expansion in its operational scale. Notably, the full-scale banking services delivered outstanding performance, generating about HK$225 million in revenue during the year, a substantial year-on-year surge of approximately 232.7%. The rising proportion of high-growth businesses and the further optimization of the revenue structure demonstrate that the company's overall strategic transformation over the past few years has begun to materialize. Looking ahead, AGTech will continue to deepen the development of its fintech ecosystem, and capitalize on development opportunities within the Guangdong-Hong Kong-Macao Greater Bay Area and international markets to steadily advance its global business footprint. -End- ABOUT THE GROUP AGTech, as a member of the Alibaba Group, was incorporated in Bermuda and its Shares are listed on GEM (Stock Code: 8279). The Company is included as a constituent stock in the MSCI World Micro Cap Index. As a comprehensive financial technology group, AGTech’s core businesses are broadly divided into four principal categories: (1) Full-scale financial services: (i) Digital payment services: (a) mCard (b) MPay (c) Merchants acquiring services 1 (ii) Full-scale banking services: (a) Digital banking services for individuals and SMEs 2 (b) Wealth management services 3 (2) Commerce enablement and local consumer services: lifestyle, culture and entertainment, marketing technical services for merchants and e-commerce platform (3) Innovative technology services for the gold and precious metals trading (4) Lottery services 4 1 This service also includes the business line previously presented under “payment‑related hardware supply”. 2 This service includes deposits, loans, transfers and cross-border remittances, cross-border e-commerce/supply chain financing, etc. 3 This service encompasses the business lines previously presented under “internet securities investment, account services, insurance agency services, and customer self-service banking outlet”. 4 This service includes lottery hardware sales, lottery offline distribution, as well as other integrated services. For more details, please visit www.agtech.com [1] Shareholders and potential investors should be aware that the Proposed Transfer of Listing is subject to, among others, the granting of relevant approval by the Stock Exchange. There is no assurance that approval and permission will be obtained from the Stock Exchange for the Proposed Transfer of Listing. Accordingly, the Proposed Transfer of Listing may or may not proceed. Shareholders and potential investors are advised to exercise caution when dealing in the Shares. 18/06/2026 Dissemination of a Marketing Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 2026-06-17 / 10:57 UTC+8 6月17日，随着A股上市公司领益智造正式披露港股IPO招股书，舜宇光学科技旗下全资投资平台——舜宇资本有限公司（以下简称“舜宇资本”）首度公开亮相。舜宇资本作为领益智造港股上市的基石投资者之一，认购金额达2000万美元，此举标志着舜宇光学科技正式开启“产品价值+资本价值”双轮驱动的战略新阶段。 作为舜宇资本成立后的首个标杆性投资项目，本次基石投资不仅是财务布局，更是舜宇光学科技深化产业协同、构建资本朋友圈的关键落子。 据悉，舜宇资本是舜宇光学科技为落实新一轮五年战略规划，在香港设立的专注于资本运作的投资平台，不以短期财务回报为目标，而是聚焦Pre-IPO投资、基石投资、海外并购，以资本为纽带，系统性构建舜宇在资本市场的“朋友圈”。 业内人士对舜宇资本的成立高度关注，认为该平台将成为舜宇光学科技掌控产业制高点、保障供应链安全、孵化新增长曲线的战略支点。 2026-06-17 此新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

EQS via SeaPRwire.com / 17/06/2026 / 10:57 UTC+8 On June 17, as A-share listed company, LINGYI iTECH (GUANGDONG) COMPANY (“LY iTECH”) formally disclosed its Hong Kong IPO prospectus, Sunny Optical Capital Limited (“Sunny Optical Capital”), the wholly‑owned investment platform of Sunny Optical Technology (Group) Company Limited, made its first public appearance. As one of the cornerstone investors in LY iTECH’s Hong Kong listing, Sunny Optical Capital subscribed US$20 million, and this move marks the official launch of Sunny Optical Technology’s new strategic phase of “dual‑drive” growth — combining product value and capital value. As the first landmark investment project since the establishment of Sunny Optical Capital, this cornerstone investment is not only a financial deployment, but also a critical move by Sunny Optical Technology to deepen industrial synergy and build its “circle of friends” in the capital market. It is understood that Sunny Optical Capital is an investment platform established by Sunny Optical Technology in Hong Kong to implement its new five‑year strategic plan, focusing on capital operations. It does not target short‑term financial returns, but instead concentrates on pre‑IPO investments, cornerstone investments, and overseas mergers and acquisitions, using capital as a link to systematically build Sunny Optical Technology’s “circle of friends” in the capital market. Industry professionals have paid close attention to the establishment of Sunny Optical Capital, believing that this platform will become a strategic fulcrum for Sunny Optical Technology to command the industrial high ground, ensure supply chain security, and incubate a new growth curve. 17/06/2026 Dissemination of a Marketing Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 17/06/2026 / 09:49 UTC+8 In the Hong Kong equity market, micro-cap stocks are routinely sidelined by institutional investors due to liquidity constraints and perceived single-business risks. However, Okura Holdings Limited (1655.HK)—a traditional operator of Japanese pachinko parlors in Nagasaki Prefecture—is quietly positioning itself at the confluence of global regulatory tailwinds. The company is orchestrating a textbook valuation re-rating, driven by the regulatory optionality within Japan's emerging casino sector. From a fundamental perspective, consensus opinion remains tethered to Okura’s mature core pachinko operations. Yet, value investors will recognize that this legacy portfolio anchors the enterprise with a resilient valuation floor. Following extensive consolidation within the Japanese gaming landscape, Okura has preserved a dominant regional footprint and robust cash generation in its home market. The stock currently trades at severely depressed multiples, with a trailing price-to-earnings (P/E) ratio around 2x and a price-to-book (P/B) ratio of approximately 0.3x. Amid macroeconomic volatility, this extreme valuation discount provides a formidable margin of safety, yielding a classic asymmetric risk-reward profile. The true catalyst, however, resides in the embedded option value of Japan’s secondary casino licenses (Integrated Resort, or IR concessions). Following the central government's approval of the MGM Resorts and Orix consortium in Osaka, Japan’s gaming ecosystem has entered a secular expansionary phase. Under current statutory frameworks, two additional casino licenses remain unallocated, and Tokyo is slated to reopen the competitive bidding window in 2027. Given that Nagasaki was a prime contender in the initial licensing tranche, local authorities are widely anticipated to mount a renewed bid. As the premier homegrown entertainment operator in Nagasaki, Okura commands deep-seated political networks and coveted commercial real estate assets, rendering it an indispensable local partner for multinational gaming concessionaires. Should the 2027 licensing momentum accelerate, Okura stands as a pure-play, micro-cap proxy primed for upward multiple expansion. While the upcoming casino bidding represents a compelling medium-term regulatory call option, management’s recent capital allocation strategy has delivered an immediate alpha generator. According to regulatory filings, Okura deployed its idle cash reserves into a pre-IPO vehicle targeting SpaceX(SPCX), securing Class A common stock at $126 per share just ahead of its Nasdaq debut. With SpaceX stock now surging past the $200 mark post-listing, Okura has locked in a staggering gain of over 58% on paper, capturing substantial balance sheet upside in a matter of days. While the absolute dollar amount is nominal relative to SpaceX's market capitalization, it represents a highly accretive asset appreciation for a company of Okura's scale. The transaction successfully breaks the valuation ceiling of a legacy entertainment stock, overlaying a premium global aerospace narrative onto its corporate profile without overshadowing its core gaming catalysts. Viewed holistically, Okura Holdings’ strategic posture reflects a calculated play on structural regulatory inflection points. The deeply discounted core business provides robust downside protection, while the 2027 Japan casino license reopening serves as a powerful catalyst to unlock balance sheet optimization. For sophisticated capital allocators hunting for deep value paired with asymmetric upside, this overlooked gaming play is emerging as a compelling dark horse. 17/06/2026 Dissemination of a Marketing Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 15/06/2026 / 20:24 UTC+8 （Hong Kong, June 15, 2026）— AGTech Holdings Limited (“AGTech”or“the Group”, HKEX Stock Code: 8279) today announced its final results for the year ended march 31, 2026. FINANCIAL HIGHLIGHTS Revenue of the Group for the year ended March 31, 2026 amounted to approximately HK$760.5 million (Year ended March 31, 2025: approximately HK$615.0 million), representing an increase of approximately 23.7% compared to the year ended March 31, 2025. For the year ended March 31, 2026, revenue contributions were mainly derived from the following businesses: Digital payment and related businesses (including commerce enablement and local consumer services and payment-related hardware sales and lease income) There was an overall increase in revenue by approximately HK$16.6 million to approximately HK$323.8 million for the year ended March 31, 2026, mainly due to the increase in transaction payment volume (TPV) driven by the rise in inbound tourists in Macau and increase in local consumption through digital payment benefiting from the consumption promotion campaign such as the “Community Consumption Grand Prize 2025”. Furthermore, the revenue from commerce enablement and local consumer services increased by approximately 85.2% to approximately HK$27.7 million for the year ended March 31, 2026, mainly driven by its continuous strategic initiatives provided to the local consumers and merchants. Full-scale banking business There was an overall increase in revenue by approximately HK$157.7 million to approximately HK$225.5 million for the year ended March 31, 2026, mainly due to (i) the consolidation of financial statements of ABM (Ant Bank (Macao) Limited) into those of the Group for the entire year, compared with only about seven months for the year ended March 31, 2025 following the completion of the Group’s acquisition of a controlling stake in ABM on September 2, 2024; (ii) the Group’s continuous innovations have led to a significant growth in both customer base and customer deposits. Lottery business There was an overall decrease in revenue by approximately HK$28.7 million to approximately HK$211.2 million for the year ended March 31, 2026, mainly due to the decrease in revenue from sales of lottery hardware by approximately HK$35.5 million as a result of the decrease in lottery hardware tenders awards and deliveries and partially offset by the increase in revenue from the provision of lottery offline distribution services by approximately HK$6.8 million. The loss for the year ended March 31, 2026 was approximately HK$54.2 million (for the year ended March 31, 2025: approximately HK$98.6 million). The overall decrease in loss for the year is primarily attributable to: (i) no fair value changes were recognized for the year ended March 31, 2026 on the convertible term loan facilities in the maximum amount of INR1,319.4 million (equivalent to approximately HK$137.3 million) previously provided by the Group to, and fully utilized by, its 45%-owned joint venture company in India, First Games Technology Private Limited (“JV”), as compared to a fair value loss of approximately HK$70.9 million for the year ended March 31, 2025. During the year ended March 31, 2026, the Group has entered into a mutual agreement with the JV for the termination of the Facilities and a gain on derecognition of approximately HK$3.5 million was recognized by the Group; and (ii) the decrease in finance income by approximately HK$14.0 million to approximately HK$30.3 million (for the year ended March 31, 2025: approximately HK$44.3 million) mainly due to the decrease in market interest rates for the year ended March 31, 2026 as compared to the corresponding period in 2025. BUSINESS REVIEW During the reporting period, the proportion of the Group's high-growth businesses continued to rise, optimizing the revenue structure and driving steady improvement across key operating indicators. These trends signal an accelerated shift from a "lottery + payment" provider to an “integrated fintech platform”. Core business segments are now working in synergy: alongside our leading position in digital payments, our full-scale banking services are growing rapidly, while innovative technology services for the gold and precious metals trading have opened up new growth horizons. Overall, the initial results of the strategic transformation are beginning to materialize. The Group’s fintech businesses have evolved into a digital ecosystem (as outlined in the diagram above). Full-scale Financial Services Leveraging the deep synergy between Macau Pass and ABM, the Group is comprehensively building a fintech ecosystem that encompasses both high-frequency payments and full-scale financial services. Digital Payment Services The Group's digital payment business is primarily conducted through Macau Pass, which is one of the leading digital payment service providers in Macau, principally engaged in mCard, MPay and merchants acquiring services. mCard is a contactless payment card widely used by Macau residents and visitors. There are currently over 6.0 million mCards in issuance, supporting local public transportation and over 30,000 consumption points across Macau. During the reporting period, mCard continuously deepened its regional connectivity strategies, in collaboration with cities across the Chinese Mainland, including Zhuhai and Wuhan, we launched the “Zhuhai-Macao Public Transport Card”,“Wuhan-Macau Intercity Card” , etc. At the same time, we subsequently launched a series of creative products, including the NBA China Games mCard, the Capybara MINI mCard, moving beyond the traditional transit card role and further promoting brand rejuvenation. The cross-border payment service was also optimized. With the addition of a top-up service option for Alipay users on September 26, 2025, it has significantly enhanced the convenience of payment and travel for tourists from Chinese Mainland in Macau. MPay is one of the most widely used e-wallets among Macau residents，with approximately 1.73 million registered users. It has become a Super App that covers dining, transportation, tourism, entertainment, online and offline shopping, finance and cross-border services and payments. On the local ecosystem front, MPay has continuously deepened its local digital ecosystem by launching the MPay Tap! Function and extending the“Amap Ride-Hailing” mini-app to the local Macau market. Meanwhile, its cross-border payment ecosystem has shown strong growth momentum. During the reporting period, the number of cross-border payment transactions and the total transaction payment volume increased by approximately 43% and approximately 44% year-on-year, respectively. In terms of international payment networks, MPay now supports users in about 60 countries and region. To facilitate northbound consumption and travel by Macau residents, it has been continuously enriching its "Cross-Border Zone" ecosystem, which now integrates approximately 90 popular mini-apps in the Chinese Mainland, including Amap Ride-Hailing, Meituan Takeout, and transit QR code of Guangzhou Metro. We are also one of the leading acquirers in Macau. Our acquiring services support travellers from over 10 overseas countries and region to use their home country/region’s e-wallets in Macau. During the reporting period, Macau Pass pioneered the introduction of innovative payment solutions exemplified by Alipay Tap! and MPay Tap! Features, and deepened scenario-based cooperation with local business partners including Sands China. As of March 31, 2026, Alipay’s innovative payment method Alipay Tap! has covered over 8,000 merchant stores across Macau. Full-scale Banking Services The Group's banking business is conducted by ABM (the “Bank”). ABM is a local full-scale bank in Macau holding a full banking licensce, providing comprehensive financial services including convenient account opening, payment and spending, global remittance, savings and wealth management (including insurance agency), and credit services to individuals and SMEs users. During the reporting period, the Bank continues to improve the full range of product services system including deposits, loans, remittances, currency exchange, and investments. The Bank also advanced its offline expansion strategy, opening its first self-service outlet in October 2025 and will consider setting up other wealth management centers in the future, gradually forming a comprehensive banking service model that integrates online digital capabilities with an offline service network. In addition, we established an online insurance payment zone and reached an agency cooperation agreement with HSBC insurance products, further expanding the product portfolio. In terms of customer management, the bank also focuses on youngster and endeavors to reach users with differentiated services through online operations and offline outlets, forming a distinct customer service advantages over conventional banks. During the reporting period, the Bank achieved growth in both customer base and fund size, with the total number of individual customers increasing by approximately 76% year-on-year and total deposits growing by approximately 235%. Commerce Enablement and Local Consumer Services Leveraging MPay’s large user base and payment traffic, together with the synergistic advantages of the mCoin and mPass platforms, the Group continues to convert online traffic into offline commercial value,empowering local business development. Leveraging the synergies of the MPay payment ecosystem, mPass provides Macau residents and tourists with a comprehensive lifestyle and travel service platform offering a wide range of services across dining, shopping, entertainment, events and high-end customised travel experiences. During the reporting period, mPass in collaboration with the Macau Economic and Technological Development Bureau and Damai, launched the “Concert + Community Consumption Benefits” campaign, effectively directing concert-goers to communities such as the Zona de Aterros do Porto Exterior (“ZAPE”,新口岸填海區). Meanwhile, it collaborated with MPay to support government and commercial initiatives to boost consumption, such as the “National Games Boost • Community Consumption Grand Prize”, and the “POP MART Macao Citywalk” (與POP MART漫游澳門), effectively increasing users’ spending activity. Additionally, during the reporting period, mPass has also supported over 130 performances and events in Macau. mCoin activates the points economy: mCoin is MPay’s exclusive points and benefits platform. During the reporting period, the mCoin platform has newly launched an mCoin gift feature. As of March 31, 2026, the cumulative volume of mCoins transferred via the gift function reached approximately 1 billion mCoins. The platform also launched the “Value Buy” (抵到爆) mCoins redemption program, collaborating with high-quality merchants to provide exclusive products, thereby achieving a mutually beneficial promotion of advantages for users and increased traffic for merchants. During the reporting period, the Group continued to deepen partnerships with product partners, leveraging digital technology to empower local business upgrades and the development of smart cities. In addition to collaborating with Alipay and Sands China to launch the Alipay Tap! Service at Sands Resorts Macao, we also collaborated with Amap to launch the “Cool Travel Festival” (清涼出行節), the “Amap Street Stars -Macao Authentic Delicacies Ranking” and the “Macao City Life Support Program”. These initiatives not only provided comprehensive support for Macau’s local merchants and empower local small and medium-sized merchants in their digital transformation and service capability upgrade, but also contributed to the growth of community economies. Furthermore, we successively established strategic cooperation with Huawei Services (Hong Kong) Limited, China Telecom (Macau) Limited, China Arts and Entertainment Group Ltd., Damai Entertainment and the Galaxy Macau™ integrated resort. These collaborations aim to explore opportunities in areas such as digital service innovation, smart city development, and cultural content growth. Innovative Technology Services for the Gold and Precious Metals Trading As part of the Group’s innovative financial strategy, the Group will design, develop, and maintain a secure and reliable electronic trading, clearing and settlement platform for HKGX and its market participants. The platform will integrate spot, futures, digital gold, B2C transactions, clearing and settlement center, over-the-counter (OTC) trading, membership management and a unified risk control system. It will support both offshore and onshore Renminbi, featuring multi-currency pricing and settlement capabilities, multilingual support, and an open and compatible architectural design. The platform aims to enhance market efficiency, connect global investors, and help strengthen Hong Kong’s position as an international gold hub. Lottery Services The lottery business maintained steady growth. The Group is one of the leading suppliers of lottery terminals in China. During the reporting period, the Group won 12 lottery hardware tenders to supply lottery terminals to the Sports Lottery Administration Centers in a number of provinces and municipalities, including Hubei, Hainan, Shandong, Tianjin, Guizhou, Jiangsu, Shaanxi, Guangdong, Fujian and Chongqing. BUSINESS OUTLOOK The Group is dedicated to becoming a leading global comprehensive financial technology group. With full-scale financial services, commerce enablement and local consumer services, and innovative technology services for the gold and precious metals trading as its core, the Group aims to build a comprehensive digital ecosystem and create a new paradigm for modern financial services. The Group will continue to strengthen its “payment + finance + technology” infrastructure. By offering full-scale banking services, e-wallet, acquiring services, mCard, multipurpose digital payment system and other services, we will continuously deepen the development of service scenarios to enhance the payment experience for local residents and tourists, while striving to promote mobile payment and inclusive finance in Macau, and contribute to its smart city transformation. Leveraging its ecosystem collaboration with Alibaba Group and Ant Group, and capitalizing on the global connectivity advantages of Alipay+, the Group will further provide support for more electronic payment tools from overseas countries and regions to facilitate the consumption of visitors to Macau, and achieve cross-border payment facilitation. Additionally, the Group will fully leverage its strengths in content and channels to provide Macau merchants with increased online exposure and digital upgrade solutions, empowering them to achieve digital transformation, thereby driving Macau’s local economic development and supporting the construction of a “World Centre of Tourism and Leisure”. On this basis, the Group will connect scenarios and resources of the ecosystem with payment plus full-scale financial services, leverage internal business synergies to continue to expand its diversified business portfolio. We will also further explore additional commercialization opportunities across the digital payment ecosystem, e-commerce, digital media and entertainment, and cultural entertainment markets, continuously enriching the value proposition of our digital ecosystem. Looking ahead to the Web3.0 era, the Group has been actively expanding into innovative finance. We are currently accelerating the deep integration of gold and precious metals trading with cutting-edge technologies, striving to build an innovative trading platform with international competitiveness. Moving forward, we will continue to deepen our strategic layout. By leveraging technology-driven initiatives and ecosystem co-creation, we aim to constantly expand the application boundaries of precious metals trading technology, injecting new vitality and momentum into the financial market development of the Guangdong-Hong Kong-Macao Greater Bay Area and beyond. With roots in Macau and sights set on the global stage, the Group will continue to invest resources to improve its technological infrastructure. Focused on user needs, we will continuously deepen service scenarios, expand our global financial service footprint, seek innovative business opportunities and continue delivering on our commitment to provide long-term sustainable growth for the shareholders. -End- ABOUT THE GROUP AGTech, as a member of the Alibaba Group, was incorporated in Bermuda and its Shares are listed on GEM (Stock Code: 8279). The Company is included as a constituent stock in the MSCI World Micro Cap Index. As a comprehensive financial technology group, AGTech’s core businesses are broadly divided into four principal categories: (1) Full-scale financial services: (i) Digital payment services: (a) mCard (b) MPay (c) Merchants acquiring services 1 (ii) Full-scale banking services: (a) Digital banking services for individuals and SMEs 2 (b) Wealth management services 3 (2) Commerce enablement and local consumer services: lifestyle, culture and entertainment, marketing technical services for merchants and e-commerce platform (3) Innovative technology services for the gold and precious metals trading (4) Lottery services 4 1 This service also includes the business line previously presented under “payment‑related hardware supply”. 2 This service includes deposits, loans, transfers and cross-border remittances, cross-border e-commerce/supply chain financing, etc. 3 This service encompasses the business lines previously presented under “internet securities investment, account services, insurance agency services, and customer self-service banking outlet”. 4 This service includes lottery hardware sales, lottery offline distribution, as well as other integrated services. For more details, please visit www.agtech.com 15/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS Newswire / 09/06/2026 / 16:00 UTC+8 (9 June 2026, Hong Kong) Waton Financial Limited Unveils MoTA: An AI-Native Investment Team Operating System and Agent Marketplace That Lets Anyone Build, Manage, and Command Their Own Professional Investment Research Team Waton Financial Limited today unveiled MoTA (Manager of Trading Agents), an AI-native investment team operating system and Agent marketplace that redefines what AI can do for investors. MoTA is not a stock-picking chatbot or a black-box trading bot. It is a platform designed to let users build, manage, and command their own team of specialized AI Agents across the full investment workflow — from portfolio definition to trade execution. The Problem Professional investment research has always required a team: factor researchers, fundamental analysts, technical analysts, risk managers, portfolio constructors, and trade execution officers. Each role demands specialized talent and expensive infrastructure. For individual investors and small teams, assembling such a capability has been cost-prohibitive — until now. The Solution MoTA transforms the user from a passive consumer of AI signals into an active leader of an AI-powered investment team. Its four integrated modules work together to deliver a seamless, end-to-end experience. First, Talents — the Agent Marketplace. Users browse, compare, and hire specialized AI Agents by role. Each Agent is purpose-built for a specific investment function — fundamental analysis, technical analysis, risk management, trade execution, and more. Agents can be swapped and composed as strategies evolve. Second, Team — composing your investment team. Users assemble multiple Agents into a structured team. Analysts feed research inputs, the Portfolio Manager evaluates and writes memos, the Risk Manager reviews exposure, and the Trader validates routing. The human user retains final sign-off authority at every stage. Third, Portfolio — the portfolio cockpit. A real-time overview of holdings, assets, P&L, risk, and exposure. Users see exactly what is moving across positions, where risk sits, and where returns originate — all in one unified view. Fourth, Decision — the Decision Center. Every Agent-generated suggestion surfaces in the Decision Center with full context: source Agent, signal, reasoning, and current status. Users can click into the full workflow or execution path, compare competing analyses, and manage an actionable queue of decisions. Every recommendation is structured, traceable, and auditable. These four modules connect in a continuous workflow: Portfolio to Decision to Team to Trade. Why MoTA Is Different Traditional AI investing tools offer a single AI chat box, scattered research answers, black-box signals, no role separation, and AI value that is hard to measure. Reviews are tied to AI silos. MoTA provides a multi-Agent investment team, a connected Portfolio-to-Trade workflow, an auditable Decision Center, dedicated Analyst and PM and Risk and Trader roles in coordination, unified metrics such as ROI and win rate and cost per run and override rate, and a unified path for portfolio, decisions, Agents, and trades. The Vision Behind MoTA Waton Financial Limited's mission with MoTA is clear: to make professional-grade multi-agent investing tools more accessible, more transparent, and more user-controlled. MoTA does not replace human judgment — it amplifies it. The platform frees users from the burden of being a full-stack investment expert and elevates them to a higher role: the builder, manager, and decision-maker of their own AI investment team. As AI moves from content generation into workflow execution, investing — inherently a multi-role, multi-step, multi-constraint process — is a natural fit for this transformation. MoTA is designed to bridge the gap between what AI can do and what the investment workflow actually needs. About MoTA MoTA (Manager of Trading Agents) is Waton Financial Limited's flagship AI-native investment team operating system and marketplace for specialized investing Agents. It enables users to create fully customizable investment teams, assign specialized AI Agents to each role, and receive structured, traceable, and auditable investment suggestions across the entire Portfolio-to-Trade workflow. About Waton Financial Limited Waton Financial Limited is a publicly listed financial services and technology company that designs, owns, and operates the MoTA platform. Waton is committed to building AI-native infrastructure for investment teams and making professional-grade multi-agent investing tools accessible to a broader audience. Welcome to MoTA. Welcome to the new era of investing. Media Contact Email: ir@watonfinancial.com Website: https://wtf.us Explore MoTA: https://mota.ai Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those expressed or implied. This is not investment advice. Past performance does not guarantee future results. 09/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com View original content: EQS News

EQS via SeaPRwire.com / 2026-06-12 / 15:02 UTC+8 ASCO 2026公布的多项临床数据进一步验证了CS2009的三靶点协同机制，并支持其作为新一代肿瘤免疫治疗（I/O）骨架药物的重要开发潜力。 一、三抗设计逻辑与差异化优势 1、相较VEGF联合PD-1具有更大的长期生存获益潜力，同时CTLA-4相关毒性低、耐受性良好 CS2009通过PD-1、VEGF和CTLA-4三靶点协同设计，旨在同时恢复T细胞效应功能、改善肿瘤微环境并增强T细胞初始激活，从而实现更深、更持久的抗肿瘤免疫应答。 • CTLA-4模块差异化设计：通过使外周CTLA-4单阳性T细胞免于过度激活，降低系统性免疫毒性，结合VEGF介导的肿瘤组织富集效应，在保留CTLA-4免疫激活作用的同时显著改善耐受性。临床数据显示，CS2009的CTLA-4相关毒性明显低于传统CTLA-4抗体治疗方案，免疫相关不良事件（irAE）发生率降至与PD-1单抗和双抗接近的水平。 • 持续给药优势：传统CTLA-4抗体通常仅能耐受两至三次给药，而CS2009可持续给药，从而更充分地发挥CTLA-4模块的作用。该模块不仅可以启动与增强对已存在的肿瘤抗原的免疫反应, 还能针对后续发生的新肿瘤抗原激活新的T细胞克隆，持续扩增抗肿瘤T细胞库。结合CS2009良好的耐受性，这一机制有望带来更持久的免疫应答，支持长期临床获益和延长患者生存。 • 药效学验证：观察到ICOS（T细胞活化标志物）呈剂量依赖性上升，作为CTLA-4通路活化后公认的药效学标志物，ICOS上调提示CS2009能够持续促进T细胞初始激活与克隆扩增，验证了其CTLA-4模块的生物学活性，并为长期抗肿瘤免疫应答提供生物学依据。 （行业挑战： 历史上多数抗VEGF联合PD-(L)1方案主要改善PFS，而OS获益存在较大不确定性。CS2009通过引入CTLA-4机制，力图突破这一局限。） 2、低VEGF相关毒性，支持更充分的治疗暴露和持续获益 药效学数据显示： • 给药后循环VEGF水平持续下降，经过147天随访仍未观察到明显反弹趋势。 这一现象与传统抗VEGF抗体或PD-1/VEGF双抗观察到的结果存在差异，可能与CS2009在肿瘤微环境中富集并通过CTLA-4介导内吞清除VEGF-抗体复合物有关，从而减少VEGF及其抗体结合复合物回流至外周循环，有助于降低高血压、蛋白尿等VEGF相关系统性毒性。 临床数据显示： • VEGF相关≥3级治疗相关不良事件（TRAE）发生率仅为5.1%，明显低于部分已报道的VEGF双抗方案。 （行业挑战：VEGF既是重要疗效驱动因素，也是联合治疗中主要毒性来源之一；高龄及高危患者毒性风险更高，可能影响生存获益。如何平衡疗效与耐受性，是VEGF赛道长期未解决的问题。） 3、冷肿瘤中持续观察到积极信号，体现CTLA-4模块潜在价值、验证三靶点协同机制 在多个传统I/O敏感性较低的瘤种中，包括：免疫治疗耐药非小细胞肺癌（NSCLC）、pMMR/MSS转移性结直肠癌（mCRC）、软组织肉瘤（STS）、非透明细胞肾癌（nccRCC），均观察到积极的临床活性。这一结果提示，CS2009通过同时阻断PD-1和CTLA-4，并结合VEGF机制，能够增强T细胞初始激活、扩展T细胞克隆谱、促进长期免疫记忆和持续抗肿瘤作用，同时改善肿瘤微环境中T细胞浸润，使免疫应答覆盖更多原本对I/O治疗不敏感的肿瘤。 多个冷肿瘤中的一致性疗效信号进一步支持，CS2009通过PD-1、CTLA-4和VEGF三靶点的协同作用，有能力重塑免疫抑制微环境，扩大免疫获益人群，并显示出突破传统PD-1单抗及PD-1/VEGF双抗疗效边界的潜力。 （行业挑战： 对于I/O不敏感冷肿瘤，目前仍缺乏真正有效的免疫治疗方案，PD-1联合CTLA-4仍是国际公认的重要突破方向之一。） 4、鳞癌与非鳞癌均观察到一致获益，体现广泛适用性 • 在NSCLC多个治疗场景中：鳞癌与非鳞癌患者均观察到相近缓解率。 CS2009目前显示出跨组织学亚型的一致获益趋势，提示其机制可能不依赖于特定病理类型，有望覆盖更广泛的NSCLC患者人群，并提高未来全球注册试验成功的确定性。 （行业挑战：鳞癌与非鳞癌之间往往存在明显的疗效差异，限制了部分产品的适应症拓展和商业化空间。） 二、安全性优势明确，VEGF毒性显著低于双抗 截至目前I期临床数据显示，在混合瘤种中（N=118）： • ≥3级TRAE发生率：24.6%； • ≥3级irAE发生率：12.7%； • VEGF相关≥3级TRAE发生率：5.1%。 聚焦NSCLC后线队列（n=57）的安全性： • ≥3级TRAE发生率：19.3%； • ≥3级irAE发生率：12.3%； • VEGF相关≥3级TRAE发生率：5.3%； 与I期多线经治混合瘤种人群整体的安全谱一致。 整体上： • CTLA-4相关毒性得到很有效的控制； • 未观察到非预期的安全性信号； • 整体安全性特征接近PD-1/VEGF双抗水平，VEGF毒性显著低于双抗。 这一安全性表现为后续长期给药和全球注册开发提供了重要基础。 三、疗效数据：冷肿瘤领域展现差异化价值 CS2009在多种难治性冷肿瘤中显示出有意义的临床活性，凸显其差异化的机制 1、结直肠癌后线单药（pMMR/MSS mCRC）： • 入组患者均为经治的难治性CRC，包括BRAF突变型和右侧结直肠癌； • CS2009单药：ORR 25%，DCR 87.5%。 考虑到传统后线治疗ORR通常仅为个位数水平，该结果已展现出具有临床意义的抗肿瘤活性。 更重要的是，疗效信号出现在典型I/O冷肿瘤人群中，进一步支持CTLA-4模块带来的潜在差异化价值。 2、一线联合XELOX治疗（pMMR/MSS mCRC）： • 研究未筛选左右半结肠、分子亚型或肝转移状态，入组人群更接近真实世界临床实践。 • 截至目前：6例患者均出现肿瘤缩小，3例首次疗效评估即达到PR • ORR 66.7%，DCR 100%。 虽然目前样本量仍然较小，但已观察到高度一致的早期疗效信号，为后续全球注册开发提供了积极支持。 公司计划继续扩大样本量至40例，以形成更完整的概念验证（POC）数据包，用于后续与包括美国食品药品监督管理局（FDA）和中国国家药品监督管理局（NMPA）在内的全球监管沟通III期全球注册临床试验方案。 3、其他冷肿瘤 • 软组织肉瘤（STS）后线单药：ORR 33.3%，DCR 66.7%； • 非透明细胞肾细胞癌（nccRCC）后线单药：ORR 33.3%，DCR 100%； • 患者疗效持久：I期首位患者（澳洲女性）12个月肿瘤持续缩小超40%。 四、NSCLC：多维度数据支持全球注册开发 维度一：后线NSCLC单药（IO/化疗/ADC/双抗经治） • 30mg/kg剂量组整体ORR 24%（鳞癌25%，非鳞癌23.1%，获益一致），DCR 60%； • 二线NSCLC（30mg/kg，IO+化疗经治）数据进一步提升：ORR 30.8%，DCR 84.6%。 在此类经PD-(L)1治疗后患者中，目前标准治疗ORR通常较低，因此CS2009已展现出具有竞争力的单药活性。 同时观察到： • 6个月缓解持续时间（DOR）率超80%（即超过80%的患者在6个月时仍能维持缓解）； • 患者缓解深度随时间持续增加； • DOR数据仍在持续成熟中。 维度二：后线NSCLC联合多西他赛 • 6例患者全部肿瘤缩小，ORR 66.7%，DCR 100%。 尽管目前样本量有限，但这一结果在同类研究中已非常具有竞争力。 公司计划进一步扩展至20例患者，以支持后续注册开发决策。 维度三：一线NSCLC单药（PD-L1 TPS≥50%） • 16例患者，ORR 81.3%，DCR 100%； • 鳞癌ORR 87.5%，非鳞癌ORR 75%，获益一致； • 较早时（2026年3月）数据显示10例患者有9例达到 PR，本次新增的6例患者有4例在首次肿评即达到PR，目前总共已观察到13例PR； • 所有应答患者均未出现快速进展，患者缓解深度随时间持续增加。 尽管跨研究比较存在局限性，但当前CS2009单药在一线NSCLC（PD-L1 TPS≥50%）中的ORR已达到国际同类研究中的领先水平（best-in-class range），显示出极具竞争力的临床开发潜力。 注：PD-L1 1%-49%人群数据仍在持续成熟中。 维度四：一线NSCLC联合化疗（鳞癌，PD-L1低表达/阴性） • 截至目前8例鳞癌患者中，7例均为PD-L1≤1%低表达/阴性，1例为PD-L1≤5%低表达，中位年龄70岁； • ORR 75%，DCR 100%；PD-L1阴性患者ORR达100%； 特别值得关注的是： • PD-L1阴性患者中观察到100%缓解率； • 高龄患者群体中同样观察到优异疗效。 尽管仍需更长时间随访验证，但已显示出积极且一致的早期疗效信号。 注：一线鳞状NSCLC联合化疗全人群、一线非鳞状NSCLC联合化疗仍在入组中，数据后续披露。 五、全球注册开发策略 CS2009正按照全球多中心开发路径推进。 • 入组速度极快，数据包准备节奏匹配，与监管沟通节点明确； • 不做单一国家注册研究，做全球多中心注册研究（MRCT），所有关键注册研究均采用国际标准治疗作为对照组（K药/K药+化疗/贝伐珠单抗+化疗），试验设计和时间窗口不受当前其他双抗/三抗竞品数据读出的干扰，具备独立推进的节奏优势。 - 2026年10月：与FDA沟通一线NSCLC联合化疗（对比K药+化疗）III期全球注册临床方案； - 2026年四季度：与FDA沟通一线mCRC联合化疗（对比贝伐珠单抗+化疗）III期全球注册临床方案； - 2027年初：与FDA沟通二线NSCLC（联合多西他赛头对头多西他赛）及一线NSCLC单药头对头K药的III期全球注册临床方案。 每个适应症需20-60例POC数据，目前公司已建立支持全球开发的临床、生产/工艺/质量（CMC）体系，为后续全球多中心III期MRCT研究奠定基础。 六、2026年重要催化剂 • 2026年8月底：中报更新ASCO后更成熟的临床数据； • 2026年10月左右：与FDA沟通一线NSCLC联合化疗III期临床试验方案； • 2026年四季度：与FDA沟通一线CRC联合化疗III期临床试验方案； • 2026年四季度：ESMO会议更新CRC、肺癌等适应症临床数据； • 2026年底：启动首批全球III期MRCT注册研究。 所有关键注册研究均采用当前国际标准治疗作为对照组，不依赖竞争产品研究进展。 七、BD进展 目前正与多家跨国药企（MNC）持续开展深入交流。合作方重点关注：三抗设计逻辑、安全性特征、NSCLC与CRC临床数据、全球注册开发路径。 随着数据持续成熟及全球开发计划推进，CS2009的差异化价值正得到越来越广泛和高度的认可。 八、管理层信心与市值管理 1、管理层及董事会增持： 近期股价波动明显偏离公司基本面进展。管理层及董事会表示，将通过增持公司股票表达对CS2009长期价值及公司发展前景的信心。 2、港股通纳入预期： 管理层表示，对公司于2026年9月调整窗口纳入港股通保持积极预期。 九、核心结论： ASCO 2026数据标志着CS2009已从机制验证阶段进一步迈向临床概念验证（POC）阶段。其差异化三抗设计不仅展现出优异的安全性特征，更在多个传统I/O冷肿瘤及肺癌人群中持续观察到具有临床意义的疗效信号与持久缓解。随着CRC和NSCLC关键项目推进全球注册开发，CS2009正逐步展露成为下一代肿瘤免疫治疗骨架药物的巨大潜力。 关于基石药业 基石药业（香港联交所代码: 2616）成立于2015年底，是一家专注于肿瘤、免疫与炎症等关键疾病领域药物研发的创新驱动型生物医药企业，致力于满足中国和全球患者的殷切医疗需求。截至目前，公司已成功上市4款创新药、获批21项新药上市申请（NDA）以及9项适应症。当前研发管线均衡配置了抗体偶联药物（ADC）、多特异性抗体、以及免疫疗法和精准治疗药物在内的16款候选药物。同时，基石药业拥有一支资深管理团队，“全链条”覆盖临床前探索、临床转化、临床开发、药物生产、商务拓展、商业运营等关键环节。如需了解有关基石药业的更多信息，请访问：www.cstonepharma.com。 投资者关系: ir@cstonepharma.com 媒体关系:pr@cstonepharma.com 前瞻性声明 本文所作出的前瞻性陈述仅与本文作出该陈述当日的事件或资料有关。除法律规定外，于作出前瞻性陈述当日之后，无论是否出现新资料、未来事件或其他情况，我们并无责任更新或公开修改任何前瞻性陈述及预料之外的事件。请细阅本文，并理解我们的实际未来业绩或表现可能与预期有重大差异。本文内所有陈述乃本文章刊发日期作出，可能因未来发展而出现变动。 声明：仅供医疗卫生专业人士交流使用。 2026-06-12 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

EQS via SeaPRwire.com / 12/06/2026 / 15:02 UTC+8 Shanghai - 12 Jun 2026 - The clinical datasets presented at ASCO 2026 further validate the trispecific synergistic mechanism of CS2009 and support its potential to become a next-generation immuno-oncology (I/O) backbone therapy. I. Trispecific Design Rationale and Differentiated Advantages 1. Greater Potential for Long-Term Survival Benefit vs. PD-1+VEGF Combinations, with Low CTLA-4-Related Toxicity and Favorable Tolerability CS2009 was designed to restore T-cell effector function, remodel the tumor microenvironment (TME), and enhance T-cell priming via simultaneous targeting of PD-1, VEGF, and CTLA-4, aiming to generate deeper and more durable anti-tumor immune responses. • Differentiated CTLA-4 Design: The CTLA-4 component is engineered to avoid excessive activation of peripheral CTLA-4 single-positive T cells, thereby reducing systemic immune toxicity. Combined with VEGF-mediated tumor enrichment, this design preserves the immune-stimulatory benefit of CTLA-4 blockade while substantially improving tolerability. Clinical data has demonstrated that CTLA-4-related toxicities with CS2009 are notably lower than that of conventional CTLA-4 antibody regimens, with immune-related adverse events (irAEs) approaching incidence typically seen with PD-1 monotherapy or PD-1-based bispecific antibodies. • Advantage of Continuous Dosing: Unlike conventional CTLA-4 antibodies, which are often limited to two or three doses due to tolerability concerns, CS2009 can be administered continuously, therefore fully leveraging the CTLA-4 mechanism—not only initiating and enhancing existing anti-tumor T-cell responses but also continuously priming new T-cell clones against newly released tumor antigens throughout treatment. This ongoing expansion of the anti-tumor T-cell repertoire, combined with CS2009’s favorable tolerability, is expected to drive more durable immune responses, prolong clinical benefit, and ultimately improve overall survival. • Pharmacodynamic Validation: Dose-dependent upregulation in ICOS, a recognized pharmacodynamic marker of CTLA-4 pathway activation and T-cell activation, were observed. The ICOS elevation suggests that CS2009 continuously promotes T-cell priming and clonal expansion, validating the biological activity of its CTLA-4 module and providing biological basis for long-term anti-tumor activity. Industry challenge: Historically, most anti-VEGF plus PD-(L)1 regimens have primarily improved progression-free survival (PFS), while overall survival (OS) benefits remains highly uncertain. By incorporating a CTLA-4 mechanism, CS2009 aims to break through this limitation. 2. Low VEGF-Related Toxicity Supporting More Adequate Treatment Exposure and Sustained Clinical Benefit Pharmacodynamic data demonstrated: • Circulating VEGF levels have declined continuously following dosing, and no clear rebound has been observed after up to 147 days of follow-up. This pattern differs from results reported with traditional anti-VEGF antibodies or PD-1/VEGF bispecifics, potentially due to CS2009’s enrichment in the tumor microenvironment and CTLA-4-mediated internalization and clearance of VEGF-antibody complexes. This may reduce reflux of VEGF and its antibody-bound complexes into the peripheral circulation, thereby lowering VEGF-related systemic toxicities such as hypertension and proteinuria. Clinical data demonstrated: • The incidence of Grade ≥3 VEGF-related treatment-related adverse events (TRAEs) is only 5.1%, notably lower than reported rates for certain VEGF-based bispecifics. Industry challenge: VEGF is both a critical efficacy driver and a major source of toxicity in combination therapies. Achieving an optimal balance between efficacy and tolerability, particularly in elderly and high-risk patients, remains a longstanding, unresolved challenge in the VEGF field. 3. Consistent Activity Observed Across Multiple “Cold” Tumors, Highlighting the Value of the CTLA-4 Module and the Trispecific Mechanism Promising anti-tumor activity has been observed in several traditionally immunotherapy-insensitive tumor types, including: Immunotherapy-resistant non-small cell lung cancer (NSCLC), pMMR/MSS metastatic colorectal cancer (mCRC), Soft tissue sarcoma (STS), Non-clear cell renal cell carcinoma (nccRCC). These findings suggest that the combined blockade of PD-1 and CTLA-4, together with VEGF modulation, may enhance T-cell priming, broaden T-cell clonal diversity, promote durable immune memory, and improve T-cell infiltration within the TME—extending immune responsiveness to tumors that were previously I/O-insensitive. The consistent efficacy signals across multiple cold tumors support the ability of CS2009’s PD-1, CTLA-4 and VEGF synergism to reshape the immunosuppressive TME, expand the I/O-benefiting population, and demonstrate the potential to transcend the efficacy boundaries of traditional PD-1 inhibitors and PD-1/VEGF bispecifics. Industry challenge: Effective immunotherapy options remain limited for cold tumors. PD-1 plus CTLA-4 blockade is still one of the most widely recognized strategies for enhancing immunotherapy responsiveness. 4. Consistent Benefit Observed Across Squamous and Non-Squamous NSCLC • Across multiple NSCLC treatment settings, comparable response rates were observed in both squamous and non-squamous patients. CS2009 is showing a trend of consistent benefit across histological subtypes, indicating that its mechanism may not depend on a particular pathologic type and may cover a broader population of NSCLC patients, enhancing the probability of success in future global registrational trials. Industry challenge: Notable differences in efficacy between squamous and non-squamous NSCLC often limit the label expansion and commercial potential of certain products. II. Favorable Safety Profile with Notably Lower VEGF-Related Toxicity Compared with Bispecifics Safety data from the ongoing Phase I study in a mixed tumor population (N=118): • Grade ≥3 TRAE incidence: 24.6%; • Grade ≥3 irAE incidence: 12.7%; • Grade ≥3 VEGF-related TRAE incidence: 5.1%. Focusing on the later-line NSCLC cohort (n=57): • Grade ≥3 TRAE rate: 19.3%; • Grade ≥3 irAE rate: 12.3%; • VEGF-related Grade ≥3 TRAE rate: 5.3%; • Consistent with the safety profile of the overall heavily pretreated mixed-tumor population. Overall: • CTLA-4-related toxicity appears very well controlled. • No new or unexpected safety signals have been identified. • The overall safety profile is comparable to that of PD-1/VEGF bispecific antibodies, while VEGF-related toxicity appears substantially lower. This safety profile provides an important foundation for long-term dosing and future global registrational development. III. Efficacy in “Cold” Tumors Demonstrates Differentiated Clinical Value CS2009 has demonstrated meaningful clinical activity across multiple “cold” tumors, highlighting the differentiated mechanism. 1. Monotherapy in Later-Line pMMR/MSS mCRC • All enrolled patients had heavily pretreated, refractory CRC, including cases with BRAF mutations and right-sided tumors. • CS2009 monotherapy achieved an ORR of 25% and a DCR of 87.5%. Given that ORR in later-line colorectal cancer are typically in the single digits, these results demonstrate clinically meaningful anti-tumor activity. More importantly, efficacy signals emerging in a typical cold-tumor population further supports the differentiated value of the CTLA-4 module. 2. Combination with XELOX in First-Line pMMR/MSS mCRC • The study did not select patients by tumor sidedness, molecular subtype, or liver metastasis; the enrolled population better reflects real-world clinical practice. • To date, all six patients have experienced tumor shrinkage, and three patients achieved a partial response (PR) at their first efficacy assessment. • ORR was 66.7%, and DCR was 100%. Although the sample size remains small, highly consistent early efficacy signals have already been observed, providing positive support for subsequent global registrational development. The Company plans to expand the cohort to approximately 40 patients to generate a more comprehensive proof-of-concept (POC) dataset for upcoming discussions with the global regulatory authorities including the U.S. Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA) on a Phase III global registrational clinical trial. 3. Other “Cold” Tumors • Monotherapy in Later-line Soft Tissue Sarcoma (STS): ORR 33.3%, DCR 66.7%; • Monotherapy in Later-line non-clear cell renal cell carcinoma (nccRCC): ORR 33.3%, DCR 100%;. • Durable responses have also been observed. Notably, the first patient enrolled in Phase I (an Australian female) has experienced sustained tumor shrinkage of more than 40% over 12 months. IV. NSCLC: Multi-Dimensional Data Support Global Registrational Development Dimension 1: Later-Line NSCLC Monotherapy (Pretreated with IO, Chemotherapy, ADCs, or Bispecifics) • Overall ORR in the 30 mg/kg cohort: 24% (squamous 25%, non-squamous 23.1%, consistent benefit); DCR 60%; • In second-line NSCLC (30 mg/kg, post IO + chemotherapy): ORR improved to 30.8%, DCR 84.6%. • In such post-PD-(L)1 patient populations, standard-of-care ORRs are generally low, thus CS2009 has demonstrated competitive single-agent activity. Additional observations include: • 6-month duration-of-response (DOR) rate exceeded 80% (i.e., more than 80% of responders remained in response at 6 months); • Depth of response has continued to deepen over time; • DOR data are still maturing. Dimension 2: Later-Line NSCLC in Combination with Docetaxel • All six evaluable patients experienced tumor shrinkage, resulting in an ORR of 66.7% and a DCR of 100%. Although the sample size is currently small, these results are already very competitive within this class of studies. The company plans to expand the cohort to approximately 20 patients to inform subsequent registrational decisions. Dimension 3: First-Line NSCLC Monotherapy (PD-L1 TPS ≥50%) • Among 16 patients, ORR was 81.3% and DCR was 100%; • Squamous ORR 87.5%, non-squamous ORR 75%, consistent benefit; • Earlier data (March 2026) showed 9 PRs out of 10 patients; among the 6 newly enrolled patients, 4 achieved a PR at their first tumor assessment, bringing the total number of PRs observed to 13; • No responding patients have experienced rapid disease progression, and patients have shown deepening responses over time. While cross-trial comparisons have limitations, CS2009’s single-agent ORR in first-line NSCLC (PD-L1 TPS ≥50%) has reached a best-in-class range among comparable studies globally, demonstrating highly competitive clinical potential. Note: Data in the PD-L1 1%–49% population continue to mature. Dimension 4: First-Line NSCLC in Combination with Chemotherapy (Squamous, PD-L1 Low or Negative) • Among 8 squamous patients enrolled to date, 7 patients have PD-L1 ≤1% (low/negative), and 1 patient has PD-L1 ≤5% (low expression); median age is 70 years; • ORR was 75% and DCR was 100%; among PD-L1-negative patients, ORR reached 100%; Particularly noteworthy: • A 100% response rate was observed among PD-L1-negative patients; • Encouraging efficacy was also observed in elderly patients. Although longer follow-up is required, positive and consistent early efficacy signals are evident. Note: Enrollment is ongoing in the first-line all-comer squamous NSCLC (Chemo Combo) and first-line non-squamous NSCLC (Chemo Combo) cohorts. Data will be disclosed subsequently. V. Global Registration Strategy CS2009 is advancing through a global multi-regional clinical development pathway. • Rapid enrollment supports timely data package generation and regulatory engagement. • Registrational studies will not be conducted in a single country; all key registrational studies will be global multi-regional clinical trials (MRCTs) using current international standard-of-care comparators (pembrolizumab / pembrolizumab + chemotherapy / bevacizumab + chemotherapy). The trial designs and timelines are independent of data readouts from other bispecific/trispecific competitors, giving CS2009 a self-determined development advantage. - October 2026: Discuss the Phase III global registrational clinical trial protocol for first-line NSCLC + chemotherapy (vs. pembrolizumab + chemotherapy) . - Q4 2026: Discuss the Phase III global registrational clinical trial protocol for first-line mCRC + chemotherapy (vs. bevacizumab + chemotherapy) . - Early 2027: Discuss the Phase III global registrational clinical trial protocol for second-line NSCLC (CS2009 + docetaxel vs. docetaxel) and first-line NSCLC monotherapy (head-to-head vs. pembrolizumab) . 20–60 patients of POC data are expected per indication. The company has already established a clinical, CMC (Chemistry, Manufacturing and Controls) and operational system that supports global development, laying the groundwork for subsequent global multi-center Phase III MRCTs . VI. Key Catalysts in 2026 • Late August 2026: Interim results update featuring more mature post-ASCO clinical data. • Around October 2026: FDA discussion regarding the Phase III global registrational clinical trial protocol for first-line NSCLC + chemotherapy. • Q4 2026: FDA discussion regarding Phase III global registrational clinical trial protocol for first-line CRC + chemotherapy. • Q4 2026: ESMO Congress – clinical data updates for CRC, NSCLC, and other indications. • End of 2026: Initiation of the first-wave global Phase III MRCTs. Importantly, all pivotal studies are benchmarked against current global standard-of-care comparators, without dependency on competitors’ development progress. VII. Business Development Progress In-depth discussions are ongoing with multiple multinational pharmaceutical companies (MNCs). Key areas of partner interest include: trispecific antibody design rationale, safety profile, clinical data in NSCLC and CRC, global registration strategy. As data continue to mature and the global development advances, the differentiated value of CS2009 is gaining increasingly broad and strong recognition. VIII. Management Confidence and Capital Markets Initiatives 1. Share Purchases by Management and the Board: Management and the Board believe that the recent share price volatility has significantly deviated from the Company’s fundamental progress. Management and Board members have expressed their confidence in the long-term value of CS2009 and the Company’s growth prospects by increasing their shareholdings. 2. Anticipated inclusion in the Hong Kong Stock Connect Scheme Management expressed a positive expectation that the Company will be included in the Stock Connect scheme at the September 2026 adjustment window. IX. Key Takeaway The ASCO 2026 data mark CS2009’s transition from mechanism validation to the clinical proof-of-concept (POC) stage. Its differentiated trispecific design not only delivers an excellent safety profile, but also consistently generates clinically meaningful efficacy signals and durable responses across a range of traditional I/O-cold tumors and lung cancer populations. As the key CRC and NSCLC programs move toward global registrational development, CS2009 is steadily emerging as a next-generation I/O backbone agent with significant potential. About CStone CStone (HKEX: 2616), established in late 2015, is an innovation-driven biopharmaceutical company focused on the research and development of therapies for oncology, immunology, inflammation, and other key disease areas. Dedicated to addressing patients’ unmet medical needs in China and globally, the Company has made significant strides since its inception. To date, the Company has successfully launched 4 innovative drugs and secured approvals for 21 new drug applications covering 9 indications. The company’s pipeline is balanced by 16 promising candidates, featuring antibody-drug conjugates (ADCs), multispecific antibodies, immunotherapies and precision medicines. CStone also prides itself on a management team with comprehensive experiences and capabilities that span the entire drug development spectrum, from preclinical and translational research to clinical development, drug manufacturing, business development, and commercialization. For more information about CStone, please visit: www.cstonepharma.com. IR contact: ir@cstonepharma.com PR contact: pr@cstonepharma.com Forward-looking statements The forward-looking statements made in this article only relate to events or information as of the date when the statements are made in this article. Except as required by law, we undertake no obligation to update or publicly revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. All statements in this article are made on the date of publication of this article and may change due to future developments. Disclaimer: only for communication and scientific use by medical and health professionals, it is not intended for promotional purposes. 12/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 12/06/2026 / 09:50 UTC+8 Chicago, Illinois - June 12, 2026 - (SeaPRwire) - Lossdog, a new financial technology platform co-founded by Tom Sosnoff and Scott Sheridan, has officially launched in the United States with a mission to give working professionals access to the same quality of compensation data that employers have long used in salary negotiations. The platform offers a single, calculated dollar figure representing a user's professional market worth, expressed as annual salary. Sosnoff and Sheridan previously co-founded thinkorswim, an online brokerage specializing in options trading that was acquired by TD Ameritrade in 2009 for approximately $750 million. The two then co-founded tastytrade, a retail brokerage and financial media network acquired by IG Group in 2021 for $1.1 billion. Lossdog marks their third major fintech venture. The platform works by analyzing a user's resume against real labor market records, including government wage data, to produce a precise professional valuation. Lossdog also includes a portfolio optimization tool that evaluates a user's investment holdings and calculates the lifetime dollar value of underperformance relative to an industry baseline. Research published by Lossdog in early 2026 found that a professional starting at $75,000 per year could leave approximately $3.9 million in uncaptured nominal earnings over a 30-year career, a figure the company attributes to structural information asymmetry in wage negotiation. A follow-up report published in March 2026 found the gap to be significantly wider for female professionals. "Most professionals leave seven figures on the table over their careers because they're negotiating blind," said Jeff Joseph, Chief Strategist at Lossdog. "We built the first AI platform that reads your resume, analyzes your skills and experience against real data, and tells you what you're actually worth down to the dollar." To mark the platform's launch, Lossdog is offering free first-year subscriptions, valued at $100 each, to its first 50,000 registered users. Those users will also share in a $1 million cryptocurrency pool, with individual awards ranging from $50 for the earliest registrants to $10 for those in later waitlist positions. The company has reported more than 25,000 waitlist registrations. Lossdog operates in a space adjacent to platforms such as LinkedIn, Glassdoor, and Payscale, but distinguishes its product by generating an individual-specific figure rather than aggregated salary ranges. The platform currently serves users in the United States. "After 40-plus years on the trading side of the business world, we are about to take on a bigger challenge," Sheridan wrote publicly ahead of the launch. About Lossdog Lossdog is a Chicago-based financial technology company co-founded by Tom Sosnoff and Scott Sheridan. The company offers a subscription-based platform that uses artificial intelligence and government labor market data to calculate the precise professional market value of individual workers and to evaluate the performance of their investment portfolios. Lossdog is currently available to users in the United States. Contact Information Brand: Lossdog Contact: Jeff Joseph Email: jeff.joseph@lossdog.com Website: https://lossdog.com 12/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 2026-06-11 / 18:43 UTC+8 业绩重点 2026财政年度，在品牌转型的持续推动下，本集团录得强劲业绩。尽管外部不确定性升温，以及黄金价格出现前所未见的波动，集团仍实现高质量盈利增长。 营业额按年增加5.3%至94,398百万港元，主要受惠于设计独特、高毛利的标志性产品系列销售贡献提升。 期内，集团录得经营溢利按年增长 27.8% 至 18,850 百万港元，股东应占溢利增加52.2%至9,004百万港元，创历史新高。 毛利率提升至32.3%，乃受惠于黄金价格飙升以及销售组合转向较有利的零售业务及设计独特的首饰。加上强劲业务表现及严谨的成本控制，经营溢利率提升360个点子至20.0%，创近五年新高。 本集团的股本回报率上升至28.4%，较过往五年的历史平均水平20.5%持续提升。 2026年2月，集团于香港开设首间全球旗舰店，并相继于中国内地（内地）及主要国际市场开设新设计门店，同时将业务拓展至奢华生活时尚领域。 董事会建议派发末期股息每股 0.45 港元，连同中期股息，全年股息每股共 0.67 港元，派息率达 73.4%，反映集团对持续为股东创造回报的坚定承诺。 财务摘要 截至3月31日止年度 2026百万港元 2025百万港元 同比变化 营业额 94,398 89,656 +5.3% 毛利 30,500 26,455 +15.3% 毛利率 32.3% 29.5% +280 个点子 经营溢利(1) 18,850 14,746 +27.8% 经营溢利率 20.0% 16.4% +360个点子 本公司股东应占溢利 9,004 5,916 +52.2% 每股盈利 基本（港元） 0.91 0.59 +53.7% 摊薄（港元） 0.90 0.59 +52.5% 每股全年股息(2) （港元） 0.67 0.52 N/A (1)毛利及其他收入的合计，减销售及分销成本以及一般及行政开支(2)2026财政年度全年度的派息率约为73.4% （中国香港, 2026年6月11日） 周大福珠宝集团有限公司（「周大福珠宝集团」、「周大福珠宝」、「集团」或「公司」；香港联交所股份代号︰1929）今天宣布截至2026年3月31日止年度的全年业绩（「2026财政年度」）。 业绩创历史新高 充分彰显品牌转型成效 2026 财政年度，全球宏观经济持续不明朗，金价亦录得前所未有的波动。尽管面对这些挑战，集团展现坚实韧性，营业额按年增加5.3%至94,398百万港元。毛利率上升280个点子至32.3%，乃受惠于黄金价格大幅度波动，以及自2024年起成功推出设计独特、高毛利的标志性产品系列销售贡献提升所带动。经营溢利增长27.8%至18,850百万港元，股东应占溢利增加52.2%至9,004 百万港元，创历史新高。经营溢利率上升360个点子至20.0%，创五年新高。 集团的股本回报率上升至28.4%，较过往五年的历史平均水平20.5%持续改善。董事会建议派发末期股息每股0.45港元，全年股息每股共0.67港元。2026 财政年度全年派息率约为73.4%。强韧的表现由以客为本的策略及三大关键增长动力所推动：（1）重塑中国奢侈品牌的全球地位、（2）强化产品组合及营运效率，以及（3）开拓新领域。 周大福珠宝集团主席郑家纯博士表示：「我们积极加大品牌投入，持续提升品牌吸引力，深化与顾客之间的情感连结，并透过沉浸式零售体验、精湛工艺及富有感染力的叙事，进一步与全球消费者建立更深共鸣，以及藉数字化互动，展现品牌如何将深厚的历史与文化艺术底蕴，融汇于当代品味生活之中。」 就全年业绩而言，周大福珠宝集团副主席郑志雯女士表示：「我们欣然见到集团录得历史新高业绩及高质量盈利，充分印证品牌转型的成效。作为全球知名中国奢侈品集团，周大福将中式美学、精湛工艺与深厚文化底蕴引领到世界舞台，并为行业树立新标准。」 重塑中国奢侈品牌的全球地位 全球奢侈品市场一直由西方文化主导。我们致力重塑全球奢华格局，向世界展现当代中国文化、创造力与卓越工艺。周大福成功推出标志性的万相系列，充分展现品牌的创新技术及设计创意，成为首个将中国美学与现代工艺巧妙融合的珠宝品牌。万相系列一经面世即引发市场热烈追捧，自今年4月开售以来至5月底，的零售值已超过5亿港元，比部分标志性产品系列开售初期成绩更为出众。另外，标志性产品系列亦发挥吸纳新客群的关键作用。例如在内地及港澳市场，购买万相系列的顾客当中，有超过20%为新客。年内，我们推出首个高级珠宝系列「和美东方」，透过植根于文化的世界级工艺弘扬东方美学，并进一步提升品牌在全球高级珠宝领域的影响力。2026 年 3 月，集团委任谢鼎鸿（David Tse）为全球创意总监。他曾任爱马仕驻中国创意总监，累积了丰富的奢侈品专业经验，将引领集团的全球故事叙述，进一步深化品牌吸引力。 我们亦持续丰富标志性产品系列，进一步强化品牌差异化。2026 财政年度， 传福系列、传喜系列及周大福故宫系列等标志性产品系列保持强劲销售势头，合共贡献集团零售值近100亿港元，而经典的传承系列则贡献了集团零售值达430亿港元。 强化产品组合及营运效率 今年2月，集团于香港尖沙咀广东道开设全球首间旗舰店，标志着品牌转型之旅的重要里程碑。该旗舰店占地约10,000 呎，是集团在香港及澳门面积最大的门店。此店特设「品牌典藏馆」，完美展现我们的历史文化、工艺及创造力。该旗舰店为顾客带来升级的零售体验，体现我们作为世界知名中国奢侈品集团的抱负。 截至2026 年财年底，我们在内地的黄金地段共设8 间新设计的高端形象门店。该等门店的生产力约为平均同店销售的8 至10 倍，当中定价首饰带来的贡献增幅尤其明显。除了这种店型，我们亦精挑人流畅旺的地段开设门店，同时优化视觉陈列、产品组合及零售体验。店龄不足两年的新店平均每月零售值达约1.6 百万港元，较去年同期大幅增长57%。鉴于新设计的高端形象门店取得理想成效，我们计划于中国内地开设更多该类门店，由目前的8 间扩展至2030 财政年度的50 间。 内地方面，我们持续推动品牌转型及优化门店措施， 2026 财政年度的同店销售上升6.9%。在香港及澳门，内地推行黄金增值税新政策后，消费者需求显著增强，2026 财政年度同店销售增长达16.8%。年内，香港同店销售增长为13.3%，澳门则为29.4%。 年内，集团进一步加强数字化进程及推出内部开发的AI 智能体平台。我们已于各关键职能部门部署超过12 个AI 智能体，涵盖门店视觉陈列、生成式人工智能珠宝创意中心和人工智能直播等领域，以提升营运效率并优化顾客互动体验。 开拓新领域 集团为2030 财政年度订立了远大的目标，包括相较2026 财政年度，将国际业务的零售值提升一倍，并把国际版图扩充至100 间门店以上。 配合集团的抱负，我们于2026 财政年度进一步将周大福品牌宇宙拓展至新地域、新渠道、新产品类别及体验，以契合顾客不断演变的生活时尚与追求。 本着重新定义全球奢侈品、进一步强化品牌对全球消费者影响力的抱负，集团相继于新加坡星耀樟宜机场、曼谷暹罗百丽宫，以及首个大洋洲的零售据点 ─ 澳洲悉尼西田购中心开设新设计的高端形象门店，带动周大福珠宝于其他市场的零售点总数增加至 63 个。2027 财政年度，集团将继续于东南亚及北美开设更多新设计的高端形象门店，并于未来两年探索中东市场的发展机会。 集团作为首个进军奢侈生活时尚领域的全球知名中国珠宝品牌，透过「周大福家居」将工艺、文化传承及对细节的极致追求，延伸至精致的家居装饰与功能性的艺术品之中，包括与知名法国高级瓷器世家Bernardaud 合作推出餐具系列，精妙融合西方工艺与中国文化传承及黄金艺术。 我们亦推出包括发饰、金章及表带配饰在内的「周大福配饰」，策略性地拓展产品类别。该等生活时尚产品组合旨在开拓多元化的细分市场、扩大客群，并吸引及接触新顾客，同时与我们的核心珠宝业务产生强大的协同效应。 2026 财政年度，我们持续积极推动与知名IP跨界合作，以触及更广泛的新客群。我们与《黑神话》的联乘系列广受市场热烈欢迎，其男性顾客占比显著高于集团平均水平。同时，集团与迪斯尼、Chiikawa及NBA的联乘项目亦成功吸纳新会员，相关IP产品的顾客中约有35%至55%为新会员，当中不乏年轻一代。 集团旗下的HEARTS ON FIRE 于年内持续推动转型，巩固其作为当代钻石珠宝品牌的定位。品牌年内展现稳健表现，其标志性 INSIDE/OUT 系列贡献品牌全球收入的 13%。同时，品牌亦新增5个零售点以拓展亚洲零售版图，进一步在多个重点奢侈品市场提升知名度。 业务展望 集团品牌转型策略的成效，充分体现在2026 财政年度稳健的财务及营运表现，以及2027 财政年度至今持续展现的韧性。 我们现正迈入数年转型旅程中的关键阶段，朝着2029 年百年里程碑迈进。我们将于2027 财政年度及其后加快步伐，并确保策略执行更具精准度与全面，重点聚焦于提升品牌吸引力、优化零售体验及加强产品差异化。 尽管外部环境仍存在波动及宏观经济不确定性，我们对所营运市场持审慎乐观态度。我们将坚定推进品牌转型进程 – 重塑中国奢侈品牌的全球地位、强化产品组合及营运效率，以及开拓新领域。 集团将持续严格执行财务纪律，加强成本及资本管理，推动高质量增长，并为股东创造可持续的盈利及回报。 2030 财政年度的抱负 在品牌迈向百年里程碑之际，我们正致力构筑一个以珠宝融入顾客品味生活的周大福品牌宇宙，进一步深化顾客对文化传承、艺术美感与精湛工艺的欣赏与共鸣。我们深信，奢华是一种跨越地域与文化的共通语言，而珠宝与品味生活的融合，正是对美学、优雅与创意的共同诠释。 展望2030年，我们为订立了以下目标： 财务表现：我们旨在实现高于市场的营业额增长，并于2030财政年度维持25%以上的高股本回报率； 门店网络升级：我们计划于2030 财政年度完成零售点的全面翻新与升级，务求在所有地点提供一致且具备鲜明特色的零售体验。同时，我们计划于中国内地开设更多新设计的高端形象门店，数量将会从目前的8间大增至2030 财政年度的50 间； 扩张国际市场：目标将国际业务的零售值较2026 财政年度提升一倍，并将国际市场门店扩张至逾 100 间； 可持续发展：我们的目标是以2024 财政年度，即我们品牌转型的起始年度为基准年，于2030 财政年度前将温室气体排放量减少50%。 ### 关于周大福珠宝集团有限公司 周大福珠宝集团的旗舰品牌「周大福」创立于1929年，一直透过别出心裁的设计和对细节的坚持，让传统成为经典。时至今日，品牌已成为了卓越品质、非凡价值及诚信可靠的代名词。 作为全球知名中国奢侈品集团，我们深信透过现代创新设计揉合传统工艺，能创造出代代相传的臻品。每个系列皆承载顾客的人生故事，庆祝他们生命中每个珍贵时刻，并在追寻幸福的旅程中带来启发和激励，让「周大福」的品牌故事深深融入顾客的生活脉络。 集团拥有丰富的品牌组合，除了旗舰品牌「周大福」，还有HEARTS ON FIRE、ENZO与MONOLOGUE。我们亦积极开拓IP 联乘合作，为顾客提供多元化的选择。我们的业务网络遍布中国，且持续延伸至全球多个市场。在全球设有逾5,000 家门店，致力于全渠道为顾客提供无缝体验。 周大福珠宝集团有限公司（香港联交所股份代号：1929）于2011 年12 月在香港联合交易所主板上市，致力通过提高盈利质量和推动更高价值的增⾧，为不同持份者创造可持续的⾧期价值。 传媒垂询，请联络： 周大福珠宝集团有限公司吴海廸（Haide Ng） 企业传讯副总监 电话：（852）3115 4402 电邮：haideng@chowtaifook.com 2026-06-11 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

EQS via SeaPRwire.com / 11/06/2026 / 18:43 UTC+8 Results Highlights Chow Tai Fook Jewellery delivered strong FY2026 performance on the back of successful brand transformation, achieving high-quality earnings growth against macro uncertainties and significant gold price volatility. Revenue grew 5.3% to HK$94,398 million, underpinned by steady growth from design-led and higher-margin iconic collections. The Group achieved an operating profit of HK$18,850 million (+27.8% YoY) and a record high profit attributable to shareholders of HK$9,004 million (+52.2% YoY). Gross profit margin expanded to 32.3%, supported by higher gold prices and increased contribution from the retail business and design-led jewellery. Operating profit margin expanded 360bps to a five-year high level of 20.0% driven by strong business performance and continued disciplined cost management. Return on Equity ("ROE") increased to 28.4%, which represented a sustained improvement against our 5-year historical average of 20.5%. The Group opened its first global flagship store in Hong Kong in February 2026, alongside newly designed stores across the Chinese Mainland and key international markets, while expanding into luxury lifestyle categories. The Board has proposed a final dividend of HK$0.45 per share, bringing the full-year total to HK$0.67 per share, a payout ratio of 73.4%, reflecting our commitment to sustained shareholder returns. Financial Summary For the year ended 31 March 2026HK$ million 2025HK$ million YoY Change Revenue 94,398 89,656 +5.3% Gross profit 30,500 26,455 +15.3% Gross profit margin 32.3% 29.5% +280 bps Operating profit(1) 18,850 14,746 +27.8% Operating profit margin 20.0% 16.4% +360 bps Profit attributable to shareholders of the Company 9,004 5,916 +52.2% Earnings per share Basic (HK$) 0.91 0.59 +53.7% Diluted (HK$) 0.90 0.59 +52.5% Full year dividend per share(2) (HK$) 0.67 0.52 N/A (1) Aggregate of gross profit and other income, less selling and distribution costs and general and administrative expenses (2) The payout ratio for FY2026 approximated 73.4% (Hong Kong, China, 11 June 2026) Chow Tai Fook Jewellery Group Limited (“Chow Tai Fook Jewellery Group”, the “Group” or the “Company”; SEHK stock code: 1929), today announces its annual results for the year ended 31 March 2026 ("FY2026"). Record Results Underscore the Continued Success of Brand Transformation The Group demonstrated strong resilience as revenue grew 5.3% to HK$94,398 million in a year marked by macroeconomic uncertainty and significant gold price volatility. Gross profit margin of 32.3% was up 280bps, driven by the surge in gold price and a higher contribution from the design-led and higher- margin iconic collections, successfully launched since 2024. Operating profit grew 27.8% to HK$18,850 million and profit attributable to shareholders grew 52.2% to a record high HK$9,004 million. Operating profit margin of 20.0% was up 360 bps to a five-year high level. The Group’s Return on Equity ("ROE") increased to 28.4%, which represented a sustained improvement against our 5-year historical average of 20.5%. The Board has proposed a final dividend of HK$0.45 per share, bringing the dividend per share for the year to HK$0.67, a full-year payout ratio of 73.4%. The strong performance was powered by a customer centric approach driven by three key levers of growth: (1) Redefining Chinese luxury globally, (2) Rejuvenating portfolio and operational efficiency and (3) Reimagining new horizons. Dr. Henry Cheng, Chairman of Chow Tai Fook Jewellery Group, said, “We are committed to investing boldly in our brand – elevating desirability, forging deeper emotional connection with customers, and expanding our global resonance through immersive retail experience, exquisite craftsmanship, compelling storytelling and digital engagement that blends our rich heritage and cultural artistry with contemporary lifestyle.” Commenting on the annual results, Ms. Sonia Cheng, Vice-chairman of Chow Tai Fook Jewellery Group, said, “We are delighted that the Group achieved record high results and high-quality earnings, validating the success of our brand transformation. As a leading global Chinese luxury group, Chow Tai Fook is charting a course to bring Chinese aesthetics, craftsmanship, and heritage storytelling to the world stage while setting a new benchmark for the industry. Redefining Chinese Luxury Globally The global luxury landscape has been dominated by Western culture. Our ambition is to redefine Chinese luxury globally, showcasing the contemporary Chinese culture, innovation and exquisite craftsmanship to the world. The successful launch of our signature collection – DAWN Collection, has clearly demonstrated Chow Tai Fook’s innovation and creativity, being the first jewellery brand to blend Chinese aesthetics with modern craftsmanship. Since its launch in April 2026 till the end of May 2026, DAWN Collection has delivered remarkable initial results, with Retail Sales Value (“RSV”) of over HK$500 million, outperforming the debut of some of the signature collections to date. Furthermore, more than 20% of customers purchasing this Collection were new to us in the Chinese Mainland, Hong Kong and Macao, underscoring the effectiveness of our signature collections in driving new customer acquisition. During the year, we unveiled our first High Jewellery Collection, “Timeless Harmony”, championing Eastern aesthetics through culturally rooted, world‑class craftsmanship and expanding the brand’s presence in the global high jewellery segment. In March 2026, we appointed David Tse as Global Creative Director, bringing deep luxury expertise from his tenure as Creative Director at Hermès in China, to lead our global storytelling and deepen brand desirability. Blending heritage with contemporary designs, our signature collections continue to resonate with the growing base of culturally conscious consumers. The Rouge Collection, Joie Collection and Chow Tai Fook Palace Museum Collection sustained strong sales momentum in FY2026, contributing close to HK$10 billion to our RSV, while the iconic HUÁ Collection contributed HK$43 billion to our RSV. Rejuvenating Portfolio and Operational Efficiency In February 2026, the Group opened its first global flagship store on Canton Road in Tsim Sha Tsui, Hong Kong, marking a significant milestone in its brand transformation journey. The approximately 10,000-square-foot flagship is the Group’s largest store across Hong Kong and Macao, showcasing the brand’s nearly century-long legacy, craftsmanship and creativity through it’s “Heritage Pavilion” and diverse offerings. The flagship offers consumers an elevated retail experience that reflects our evolving ambition as the leading global Chinese luxury group. As of FY2026, we had a total of 8 newly designed luxury-format stores in prime locations in the Mainland. These stores delivered significantly higher productivity, which was approximately 8 to 10 times the average Same Store Sales (“SSS”). These newly designed stores also had a substantially higher contribution from fixed-price jewellery. We also selectively opened stores in high-footfall locations, backed by enhanced visual merchandising, optimised product mix and elevated retail experience. As a result, the average monthly RSV of new stores aged less than two years reached approximately HK$1.6 million, up 57% YoY. In view of the success of the newly designed luxury-format stores, we plan to expand its network in the Mainland from the current 8 stores to 50 by FY2030. In the Mainland, SSS increased by 6.9% in FY2026, supported by our ongoing brand transformation initiatives and continued store optimisation. In Hong Kong and Macao, consumer demand strengthened notably post Mainland VAT reform on gold trading, with SSS rising 16.8% in FY2026. SSS growth in Hong Kong was 13.3% and Macao was 29.4% for the year. During the year, the Group also advanced digitalisation and launched our in-house AI Agent platform, deploying over 12 agents across functions such as visual merchandising, the GenAI jewellery creative centre, and AI live streaming, to drive operational efficiency and enhance customer engagement. Reimagining New Horizons The Group’s FY2030 ambition is to double the RSV of our international operations compared to FY2026; and to have an international footprint of over 100 stores. In line with our ambition, the Group expanded the Chow Tai Fook universe into new geographies, channels, product categories, and experiences that resonate with the constantly evolving lifestyle and aspirations of customers in FY2026. With the ambition to reshape global luxury and further strengthen our brand influence among global audiences, newly designed luxury-format stores were launched at Jewel Changi Airport in Singapore, Siam Paragon in Bangkok, and Westfield Sydney in Australia – marking our first entry into Oceania. This brings the total number of CHOW TAI FOOK JEWELLERY POS in Other Markets to 63. In FY2027, we will open further newly designed luxury-format stores across Southeast Asia and North America, while exploring opportunities in the Middle East in the next two years. As the first global Chinese jewellery brand to enter the luxury lifestyle arena, the new luxury home-décor line “Chow Tai Fook Home” brings craftsmanship, cultural heritage and attention to detail to refined home décor and functional art, including tableware collections developed in collaboration with renowned French porcelain house Bernardaud, where Western craftsmanship meets Chinese cultural heritage and gold artistry. Together with CTF Accessories which covers hair adornments, gold medallions and watch strap accessories, the new lifestyle offers will capture diverse market segments, broaden our customer base and create synergies with our core jewellery business. In FY2026, we continued to collaborate proactively with renowned IPs to reach new audiences. Our Black Myth Collection received overwhelming market response, with a significantly higher male mix than the Group average. Meanwhile, collaborations with Disney, Chiikawa and the NBA attracted new loyalty members, which accounted for 35%–55% of these IP collaborations’ customers, with a significant percentage of younger generations. HEARTS ON FIRE, a member of the Group, has continued its transformation into a modern global luxury diamond jewellery brand within the Group. During the year, HEARTS ON FIRE delivered resilient performance with its iconic INSIDE/OUT Collection contributing to 13% of the brand’s global revenue. The brand also expanded its retail presence in Asia with five new luxury retail locations, strengthening visibility in key luxury markets. Business Outlook The strong financial and operational performance highlights the success of our brand transformation strategy and paves the way for further growth. We are now entering the definitive phase of our multi-year transformation journey to our centenary in 2029, accelerating the pace and ensuring the precision of our full-scale strategic execution in FY2027 and beyond. Our sharpened focus is on elevating brand desirability, enriching the retail experience, and strengthening product differentiation. Despite continuing external market volatility and macroeconomic uncertainty, we remain cautiously optimistic in the markets where we operate. We are firmly committed to our brand transformation journey – redefining Chinese luxury globally, rejuvenating portfolio and operational efficiency and reimagining new horizons. We will continue to rigorously uphold financial discipline in cost and capital management, driving high-quality growth, sustainable earnings and returns for our shareholders. FY2030 Ambitions As we approach our centenary, we envision a Chow Tai Fook universe where jewellery seamlessly intertwines with the lifestyle of our customers – enriching their appreciation of cultural heritage, artistry, and craftsmanship. We see luxury as a universal language that transcends borders and cultures, where jewellery and lifestyle come together to express a shared vision of beauty, elegance, and creativity. Looking ahead to FY2030, we have set out the following ambitious targets: Financial performance: We aim to achieve above-market revenue growth, and sustain a high ROE of above 25% by FY2030; Store network evolution: We target to complete the full renovation and elevation of our POS portfolio by FY2030, delivering a cohesive and distinctive retail experience across all locations. In parallel, we plan to expand our network of newly designed luxury-format stores in the Mainland from the current 8 stores to 50 by FY2030; International expansion: We aim to double the RSV of our international operations compared to FY2026; and to have an international footprint of over 100 stores. Sustainability: We will target a 50% reduction in Greenhouse Gas emissions by FY2030, using FY2024, the first year of our brand transformation journey, as the base year. ### Chow Tai Fook Jewellery Group Limited Since its founding in 1929, CHOW TAI FOOK, the flagship brand of Chow Tai Fook Jewellery Group, has been celebrated for its bold designs and meticulous attention to detail. Our commitment to innovation and craftsmanship has made us synonymous with excellence, value, and authenticity. As the global Chinese luxury group, we blend contemporary designs with traditional techniques to create timeless pieces. Each collection reflects our customers' stories and lives, celebrating their special moments. We aspire to inspire and captivate generations to come, weaving the story of CHOW TAI FOOK into their own. Our brand portfolio includes the iconic CHOW TAI FOOK flagship brand, HEARTS ON FIRE, ENZO, and MONOLOGUE, offering a wide variety of products that also includes an expanding range of cutting-edge IP collaborations. With over 5,000 stores worldwide, we offer a seamless client journey across all touchpoints that includes a network across China as well as a growing number of global locations. Chow Tai Fook Jewellery Group Limited (SEHK: 1929) has been listed on the Main Board of the Hong Kong Stock Exchange since December 2011. We are committed to delivering sustainable long-term value for our stakeholders by continually enhancing earnings quality and driving higher value growth. Media Enquiries: Chow Tai Fook Jewellery Group Limited Haide Ng Associate Director, Corporate Communications Tel: (852) 3115 4402 Email: haideng@chowtaifook.com 11/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 09/06/2026 / 16:00 UTC+8 (9 June 2026, Hong Kong) Waton Financial Limited Unveils MoTA: An AI-Native Investment Team Operating System and Agent Marketplace That Lets Anyone Build, Manage, and Command Their Own Professional Investment Research Team Waton Financial Limited today unveiled MoTA (Manager of Trading Agents), an AI-native investment team operating system and Agent marketplace that redefines what AI can do for investors. MoTA is not a stock-picking chatbot or a black-box trading bot. It is a platform designed to let users build, manage, and command their own team of specialized AI Agents across the full investment workflow — from portfolio definition to trade execution. The Problem Professional investment research has always required a team: factor researchers, fundamental analysts, technical analysts, risk managers, portfolio constructors, and trade execution officers. Each role demands specialized talent and expensive infrastructure. For individual investors and small teams, assembling such a capability has been cost-prohibitive — until now. The Solution MoTA transforms the user from a passive consumer of AI signals into an active leader of an AI-powered investment team. Its four integrated modules work together to deliver a seamless, end-to-end experience. First, Talents — the Agent Marketplace. Users browse, compare, and hire specialized AI Agents by role. Each Agent is purpose-built for a specific investment function — fundamental analysis, technical analysis, risk management, trade execution, and more. Agents can be swapped and composed as strategies evolve. Second, Team — composing your investment team. Users assemble multiple Agents into a structured team. Analysts feed research inputs, the Portfolio Manager evaluates and writes memos, the Risk Manager reviews exposure, and the Trader validates routing. The human user retains final sign-off authority at every stage. Third, Portfolio — the portfolio cockpit. A real-time overview of holdings, assets, P&L, risk, and exposure. Users see exactly what is moving across positions, where risk sits, and where returns originate — all in one unified view. Fourth, Decision — the Decision Center. Every Agent-generated suggestion surfaces in the Decision Center with full context: source Agent, signal, reasoning, and current status. Users can click into the full workflow or execution path, compare competing analyses, and manage an actionable queue of decisions. Every recommendation is structured, traceable, and auditable. These four modules connect in a continuous workflow: Portfolio to Decision to Team to Trade. Why MoTA Is Different Traditional AI investing tools offer a single AI chat box, scattered research answers, black-box signals, no role separation, and AI value that is hard to measure. Reviews are tied to AI silos. MoTA provides a multi-Agent investment team, a connected Portfolio-to-Trade workflow, an auditable Decision Center, dedicated Analyst and PM and Risk and Trader roles in coordination, unified metrics such as ROI and win rate and cost per run and override rate, and a unified path for portfolio, decisions, Agents, and trades. The Vision Behind MoTA Waton Financial Limited's mission with MoTA is clear: to make professional-grade multi-agent investing tools more accessible, more transparent, and more user-controlled. MoTA does not replace human judgment — it amplifies it. The platform frees users from the burden of being a full-stack investment expert and elevates them to a higher role: the builder, manager, and decision-maker of their own AI investment team. As AI moves from content generation into workflow execution, investing — inherently a multi-role, multi-step, multi-constraint process — is a natural fit for this transformation. MoTA is designed to bridge the gap between what AI can do and what the investment workflow actually needs. About MoTA MoTA (Manager of Trading Agents) is Waton Financial Limited's flagship AI-native investment team operating system and marketplace for specialized investing Agents. It enables users to create fully customizable investment teams, assign specialized AI Agents to each role, and receive structured, traceable, and auditable investment suggestions across the entire Portfolio-to-Trade workflow. About Waton Financial Limited Waton Financial Limited is a publicly listed financial services and technology company that designs, owns, and operates the MoTA platform. Waton is committed to building AI-native infrastructure for investment teams and making professional-grade multi-agent investing tools accessible to a broader audience. Welcome to MoTA. Welcome to the new era of investing. Media Contact Email: ir@watonfinancial.com Website: https://wtf.us Explore MoTA: https://mota.ai Disclaimer: This press release contains forward-looking statements. Actual results may differ materially from those expressed or implied. This is not investment advice. Past performance does not guarantee future results. 09/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 08/06/2026 / 10:13 UTC+8 On June 5, 2026, C.banner (01028.HK) announced that it will obtain controlling interests in Benyuan Zhishu, a leading domestic AI data service provider, through equity acquisition and new share subscription. Benyuan Zhishu will be consolidated into the Group’s financial statements, marking the formation of a dual-core business structure comprising “footwear+ Artificial Intelligence data”. Why data? As public data is gradually digested by large models, the critical bottleneck in AI is shifting from “whose model is bigger” to “who can continuously provide harder, more authentic, high-quality data.” Computing power can be purchased, algorithms can be replicated, but this particular task cannot be bought or expedited. In 2025, Meta invested in Scale AI at a valuation of approximately $29 billion, marking a market revaluation of this insight. The scarcity of Benyuan Zhishu lies in its position and profitability. Founded in 2015, it sits upstream in the AI industry chain and is one of the few domestic suppliers that possess comprehensive data service capabilities, including large models, world models, and embodied intelligence. It serves top-tier large model manufacturers, leading internet platforms, and eminent embodied intelligence enterprises, acting as an exclusive supplier in several high-value data categories. Its revenue in 2025 was approximately 156.2 million yuan, with a net profit of 11.1 million yuan after tax, and the first five months of 2026 have shown strong revenue growth. In an AI industry largely reliant on burning money, a data company equipped with real orders and already profitable is indeed rare. The design of this transaction also demonstrates ingenuity: it is funded entirely with the Group’s internal resources. C.banner’s footwear business generates solid cash flow and maintains a net cash position. Proceeds from the new share subscription will be invested into capacity expansion and R&D, while the founding team will retain equity holdings. Upon completion of the transaction, Benyuan Zhishu will retain its independent brand, independent operations, and data segregation. C.banner will not develop models or compete with Benyuan Zhishu’s clients, allowing industry competitors to continue using the same neutral supplier with confidence. The management of C.banner stated: “We believe that high-quality data is one of the most critical and scarce infrastructures in the era of artificial intelligence. This transaction allows the Group to enter this rapidly growing sector while maintaining a stable foundation in the consumer industry. We look forward to working with Benyuan Zhishu to continuously provide 'data fuel' of high quality to China's AI industry, creating sustainable long-term value for our shareholders under the dual-core business framework.” 08/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 04/06/2026 / 19:30 UTC+8 [Hong Kong – 4 June 2026] Newborn Town Inc., a leading global social entertainment company (Newborn Town or the company, stock code: 09911.HK) is pleased to announced that it has cancelled a total of 5,174,000 shares repurchased between 27 April and 29 May 2026, representing an aggregate repurchase consideration of approximately HK$45.32 million. Prior in March 2026, Newborn Town announced a share repurchase plan of approximately HK$300 million to be carried out over the next two years. According to the announcement, following this cancellation, the total number of issued shares will decrease from 1,413,208,391 to 1,408,034,391, and Newborn Town will no longer hold any treasury shares. The Board believes that the cancellation of the repurchased shares will enhance net asset value per share and earnings per share, which aligns with the overall interests of the Company and its shareholders. The Board will continue to review and, at its sole discretion, execute share repurchases from time to time. The Company’s continued execution of both share repurchases and share cancellations sends a clear signal of management’s confidence in Newborn Town’s long-term growth prospects, while also demonstrating its commitment to enhancing shareholder returns and improving capital efficiency. Since its inclusion in the Stock Connect in March this year, Newborn Town has seen a significant increase in trading activity, accompanied by growing participation from Southbound investors. Notably, the latest round of repurchases was conducted shortly after the release of the Company's first quarter operating update. On 22 April, Newborn Town announced its unaudited operating data for the first quarter of 2026. During the period, total revenue is expected to reach approximately RMB2,030 million to RMB2,130 million, representing a year-on-year increase of approximately 33.0% to 39.6%. Among this, revenue from social networking business increased by approximately 31.3% to 37.2% year-on-year, while revenue from innovative business surged by approximately 46.7% to 58.7%, primarily driven by the rapid expansion of its AI-powered short drama business. About Newborn Town Newborn Town has grown into a leading technology company which was listed on the Main Board of the Hong Kong Stock Exchange (HKEX) in 2019 under the stock code 9911.Committed to creating positive emotional value worldwide, Newborn Town has developed a diverse portfolio of applications in the social networking and entertainment sectors. Its social apps include MICO, YoHo, TopTop, SUGO and HeeSay, together with gaming products like Alice's Dream: Merge Games. These applications have achieved widespread acclaim, reaching over one billion users in over one hundred countries and regions.Newborn Town considers the Middle East and North Africa (MENA) region a key market and has also extended its influence in Southeast Asia, Europe, the United States, Japan, and South Korea. The company aims to become the world's largest social entertainment company. For enquiries, please contact DLK Advisory pr@dlkadvisory.com 04/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 2026-06-04 / 19:30 UTC+8 6月4日，赤子城科技发布公告称，公司已注销此前于2026年4月27日至5月29日期间购回的合共517.4万股股份，涉及总回购金额约4532万港元。 此前，赤子城科技于2026年3月宣布，计划未来两年斥资约3亿港元在市场上进行股份回购。公告显示，本次注销后，赤子城科技已发行股份总数将由14.13208391亿股减少至14.08034391亿股，公司不再持有任何库存股份。 赤子城科技董事会表示，注销购回股份将提高每股股份资产净值及每股股份盈利，符合公司及股东整体利益，董事会将继续不时检讨及全权酌情决定进行股份购回。公司近期已连续推进回购及注销动作，向市场释放出管理层对公司长期发展前景的信心，也体现出其对股东回报和资本效率的重视。 自今年3月纳入港股通以来，赤子城科技累计成交额大幅提升，南向资金参与热情持续升温。从回购时点看，此轮回购正值公司一季报发布后。4月22日，赤子城科技披露2026 年第一季度未经审核营运数据，期内总收入预期约20.30 亿~21.30亿元人民币，同比增长约33.0%~39.6%。其中，核心社交业务同比增长约31.3%~37.2%；创新业务同比增长约46.7%~58.7%，主要得益于AI驱动下短剧业务的快速增长。 2026-06-04 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php

EQS Newswire / 03/06/2026 / 11:12 UTC+8 From Cell to System. From proven manufacturing experience to localized European support. Not only broad technology coverage, but the operational stability you can depend on. June 9–11, 2026 | Booth 1-B30 European battery manufacturers are moving beyond equipment procurement toward industrial ramp-up, where yield, uptime, process discipline, and local service capability determine long-term competitiveness. As battery manufacturing moves from pilot validation toward industrial-scale production, operational reliability is becoming increasingly critical across the industry. At The Battery Show Europe 2026, Hymson returns for its fifth consecutive year with a clear message for the European market: “How we make it reliable.” From process validation to mass production. Battery industrialization is not only about installing equipment. It requires process validation, operator training, spare parts readiness, data visibility, and continuous improvement mechanisms. Over the past five years, Hymson has continued to deepen its engagement with the European market, working alongside battery manufacturers amid evolving production demands, technology transitions, and industrial-scaling challenges. This long-term collaboration has enabled Hymson to continuously refine both its technologies and manufacturing methodologies for global battery production environments. Behind this commitment is sustained investment in innovation and engineering capability. By 2025, Hymson’s cumulative R&D investment will reach USD 86 million, with 34.47% of employees dedicated to R&D. Total operating revenue is projected to reach USD 939 million in 2026, supporting continued advancement in next-generation battery manufacturing technologies and industrial delivery capability. Mid-Section Turnkey Solutions for Scalable Manufacturing At Booth 1-B30, Hymson will present its latest Mid-Section Turnkey Solution through a comprehensive product matrix and a series of scaled technology models showcasing key manufacturing innovations, alongside extensive battery process samples demonstrating end-to-end manufacturing capabilities. The scaled equipment models on display include: Solid-State Dry-Electrode Solution Film-Forming & Calendering & Lamination Integrated Machine 390 High-Speed Cutting & Stacking Machine CT Inspection Machine for Prismatic Assembly Through these scaled technology models, Hymson will provide visitors with a more intuitive understanding of process integration, equipment architecture, and manufacturing workflow within next-generation battery production environments. Hymson will also showcase: 588Ah Cell Samples Developed for Overseas Customer Requirements 588Ah Cell Cap & Can Laser Welding Samples 40+ process samples covering electrode manufacturing, surface treatment, prismatic assembly, and stacking technologies Together, these exhibits reflect Hymson’s integrated approach to mid-section manufacturing — combining process capability, operational consistency, and scalable production performance. Reliability Starts from Cell Design For Hymson, manufacturing reliability does not begin at equipment installation or even at mass production. It begins much earlier — at the cell design and manufacturability assessment stage. To support customers throughout the entire industrialization journey, Hymson provides an integrated consulting and engineering support framework covering: Cell Design to Manufacturing Production Line Planning Mass Production Line Ramp-up Support Training A key focus within this framework is manufacturability validation before mass production. For many next-generation battery technologies, laboratory-level performance alone is not sufficient for successful industrialization. To reduce scaling risks, Hymson provides DOE (Design of Experiments) and DTM-based battery process analysis to support parameter optimization, blueprint evaluation, and manufacturability feasibility study. Through this process, Hymson helps customers establish: Optimized Process Parameters Manufacturable Battery Analysis Stable Transition from Validation to Mass Production Reduced Ramp-Up Uncertainty and Operational Risks Hymson helps customers translate validated pilot-line conditions into scalable mass-production workflows with thousands of successful delivery and implementation experiences as lessons learned, transitioning into Know-How for the customers, enabling smoother and more accurate alignment between pilot validation and large-scale production environments. This approach helps minimize the risks of industrialization while accelerating mass-production readiness. Technical discussions and in-depth solution exchanges will be available throughout the exhibition. Digitalized Operations for Long-Term Stability Beyond manufacturing equipment, Hymson will also present its End-to-End intelligent manufacturing support across equipment, logistics, and operations management This includes Hymson’s intelligent warehousing & logistics solution together with the IEMS intelligent equipment operation and maintenance system. Driven by AI algorithms and 3D visual monitoring technologies, the system enables: Digital Closed-Loop Production Real-Time Operational Visibility Intelligent Equipment Maintenance Data-Driven Production Management Dark-Factory-Oriented Operation Scenarios The system supports higher levels of automation and unmanned operation where applicable by integrating manufacturing execution, logistics coordination, and equipment operation into a unified system, Hymson helps customers improve operational transparency, production efficiency, and long-term factory stability. Spare Parts Support Built Around Operational Continuity To further strengthen production reliability, Hymson continues to enhance its global spare parts service capability. Hymson provides both original Hymson spare parts and third-party qualified industrial spare parts, tailored to customer requirements, supported by flexible supply mechanisms and predictive inventory planning. The service framework helps customers secure: Critical Spare Parts Availability Improved Price and Lead-Time Predictability Reduced Downtime Risks Lower Inventory Burden Where Applicable Optimized Total Cost of Ownership (TCO) Through data-driven spare parts forecasting and scheduled replenishment systems, Hymson aims to establish a replicable, stable after-sales support structure for long-term manufacturing operations. Advancing Reliable Battery Manufacturing from Asia to Europe Returning to The Battery Show Europe 2026 for the fifth consecutive year reflects Hymson’s long-term commitment to supporting Europe’s battery manufacturing ecosystem. From process development to intelligent factory operations, Hymson continues to combine large-scale manufacturing experience from Asia with localized industrial collaboration in Europe — helping battery manufacturers build production systems designed not only for technological advancement but also for reliable long-term operation. As Hymson has always stated, visitors are invited to discuss specific challenges such as process validation, ramp-up risk reduction, equipment OEE improvement, spare parts planning, and localized service support. Company： Hymson Laser Technology Group Co., Ltd. Contact Person: liruiyu Email: liruiyu@hymson.com Website: https://www.hymson.com 03/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News. The issuer is solely responsible for the content of this announcement. Media archive at www.todayir.com View original content: EQS News

EQS via SeaPRwire.com / 04/06/2026 / 11:06 UTC+8 Hong Kong - June 03, 2026 - (SeaPRwire) - Southeast Asia is becoming a new engine of global economic growth, with Indonesia, Thailand, and Vietnam acting as the most dazzling "vibrant troika" among them. To help global enterprises seize the dividends of the Southeast Asian market, renowned media service provider SeaPRwire (https://seaprwire.com) announced today that it has successfully and deeply tapped the local mainstream media ecosystems of Indonesia, Thailand, and Vietnam, building a PR green channel reaching hundreds of millions of consumers in Southeast Asia directly for overseas enterprises. Indonesia's demographic dividend, Thailand's consumer vitality, and Vietnam's rise in manufacturing and technology have made these three countries must-contend spots for all industries going overseas. However, the Southeast Asian region features diverse languages, scattered media forms, and vastly different religious and cultural backgrounds across countries, posing enormous challenges to the PR communication of foreign brands. SeaPRwire's localized expansion this time is precisely to solve this pain point. In Indonesia, SeaPRwire has strengthened cooperation with mainstream Indonesian-language portals in Jakarta and high-traffic social media matrices; in Thailand, the platform seamlessly interfaced with core Thai-language financial and fashion lifestyle media in Bangkok; and in Vietnam, it focused its layout on technology, venture capital, and digital media highly relied upon by the younger generation in Hanoi and Ho Chi Minh City. Through this refined localized media sinking, SeaPRwire ensures that enterprise information can be accurately and losslessly delivered to the most consumable local groups. "To explore the Southeast Asian market, 'groundedness' is the primary factor," stated SeaPRwire's Southeast Asia marketing director. "We are not just translating English drafts into local languages; we are penetrating deep into the media ecosystem capillaries of Indonesia, Thailand, and Vietnam. We hope to use news storytelling that best fits local contexts to help enterprises establish a warm and trusted local brand image." About SeaPRwire SeaPRwire is Asia’s leading AI-driven earned media management platform, purpose-built to empower PR and communications professionals. Through its flagship Branding-Insight Program, the platform connects clients to over 80,000 journalists and an influencer matrix reaching 300 million followers. Leveraging advanced AI, SeaPRwire helps users identify media targets, personalize pitches, and measure PR impact across key APAC markets, including Japan, China, Korea, and Southeast Asia. Media Contact Company: SeaPRwire Contact: Media Relations Team Email: cs@seaprwire.com Website: https://seaprwire.com 04/06/2026 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.com

EQS via SeaPRwire.com / 2026-06-04 / 11:06 UTC+8 Hong Kong - 2026年6月3日 - (SeaPRwire) - 东南亚正在成为全球经济增长的新引擎，而印尼、泰国和越南则是其中最耀眼的“活力三驾马车”。为了助力全球企业抢占东南亚市场红利，知名媒体服务商 SeaPRwire 今日宣布，已成功深度打通印度尼西亚、泰国和越南三国的本地主流媒体生态，为出海企业构建了直达东南亚亿级消费者的公关绿色通道。 印尼的人口红利、泰国的消费活力以及越南的制造与科技崛起，让这三个国家成为各行各业出海的必争之地。然而，东南亚地区语言多样、媒体形态分散，且各国的宗教文化背景迥异，这给外来品牌的公关传播带来了极大的挑战。SeaPRwire 此次深入本土的拓展，正是为了解决这一痛点。 在印尼，SeaPRwire 强化了与雅加达主流印尼语门户及高流量社交媒体矩阵的合作；在泰国，平台无缝对接了曼谷核心的泰语财经与时尚生活类媒体；在越南，则重点布局了河内与胡志明市的科技、创投以及年轻一代高度依赖的数字媒体。通过这种精细化的本土媒体下沉，SeaPRwire 确保企业的信息能够准确、无损地传达给当地最具消费力的群体。 “开拓东南亚市场，‘接地气’是第一要素，”SeaPRwire 的东南亚市场总监表示，“我们不仅仅是把英文稿件翻译成当地语言，更是深入到印泰越三国的媒体生态毛细血管中。我们希望用最符合当地语境的新闻叙事，帮助企业建立起有温度、有信任度的本土品牌形象。” 关于SeaPRwire SeaPRwire 是亚洲领先的 AI 驱动型赢取媒体（Earned Media）传播管理平台，专为公关及传播专业人士打造。通过其旗舰项目 Branding-Insight，平台无缝连接超过 8 万名记者、编辑，以及坐拥 3 亿粉丝的 KOL 矩阵。借助先进的 AI 技术，SeaPRwire 帮助用户精准锁定媒体目标、定制个性化推介，并全面衡量亚太核心市场（包括日、韩、中及东南亚）的公关传播效果。 媒体联络 公司: SeaPRwire 联络: Media team 邮箱: cs@seaprwire.com 网站: https://seaprwire.com 2026-06-04 此财经新闻稿由EQS via SeaPRwire.com转载。本公告内容由发行人全权负责。原文链接: http://www.todayir.com/sc/index.php